Development of a Minority Research Recruitment Database: Assessing Factors Associated with Willingness of African Americans to Enroll by Vogel, Kristen J.
 
DEVELOPMENT OF A MINORITY RESEARCH RECRUITMENT DATABASE:   
ASSESSING FACTORS ASSOCIATED WITH WILLINGNESS OF AFRICAN AMERICANS 
TO ENROLL 
 
 
 
 
by 
 
 
Kristen Vogel 
 
 
BA, Augustana College, 2002 
 
 
 
 
 
 
 
 
 
Submitted to the Graduate Faculty of 
 
 
Department of Human Genetics, Genetic Counseling Program 
 
 
The Graduate School of Public Health in partial fulfillment 
 
 
of the requirements for the degree of 
 
 
Master of Science 
 
 
 
 
 
University of Pittsburgh 
 
 
2005 
UNIVERSITY OF PITTSBURGH 
 
GRADUATE SCHOOL OF PUBLIC HEALTH 
 
 
This thesis was presented  
 
by 
 
Kristen Vogel 
 
It was defended on 
 
April 6th, 2005 
 
and approved by 
 
 
Robin Grubs, PhD,CGC 
Assistant Professor 
Human Genetics, Graduate School of Public Health  
Co-Director, Genetic Counseling Program 
University of Pittsburgh 
 
 
M. Michael Barmada, PhD 
Assistant Professor 
Human Genetics, Graduate School of Public Health 
University of Pittsburgh 
 
 
Elizabeth (Betsy) Gettig, MS, CGC 
Assistant Professor 
Human Genetics, Graduate School of Public Health  
Co-Director, Genetic Counseling Program 
University of Pittsburgh 
 
 
Stephen B. Thomas, PhD 
Thesis Advisor  
Philip Hallen Professor of Community Health and Social Justice 
Graduate School of Public Health 
University of Pittsburgh 
 
 
 
 ii
 
_____________________ 
Stephen B. Thomas, PhD 
 
 
DEVELOPMENT OF A MINORITY RESEARCH RECRUITMENT DATABASE: 
ASSESSING FACTORS ASSOCIATED WITH WILLINGNESS OF AFRICAN AMERICANS 
TO ENROLL 
 
Kristen Vogel, MS 
 
University of Pittsburgh, 2005 
 
 
The Center for Minority Health (CMH) within the University of Pittsburgh has the mission to 
eliminate racial health disparities by 2010.  One community-based intervention focuses on 
family health histories.  Family health histories, or pedigrees, have been shown to be effective 
tools for identifying individuals at risk for common diseases who may benefit from increased 
screening or other risk reduction behaviors.  Genetic counseling graduate students provide 
individuals with information pertaining to the importance of family history information in 
reducing the risk of chronic disease.  Students travel to various locations in the African American 
community where they collect individuals’ family health histories.  Individuals who participate 
have the opportunity to enroll in the Minority Research Recruitment Database from which they 
can be contacted regarding research for which they may qualify.  This is the Center’s effort to 
increase minority recruitment.  This has public health relevance given that minorities are often 
under-represented in research and it is thought that increasing minority recruitment will aid in 
elimination of racial health disparities.  This study was developed to characterize individuals 
who elected to enroll in the database and compare them to those who declined enrollment.  
Factors for comparison include demographics, recruitment variables, opinions regarding 
research, health care, personal health, and family history.  Factors were assessed for 126 
 iii
participants of which approximately 80% enrolled in the database and 20% declined.  Analysis 
revealed that those more likely to participate in the database were female, without health 
insurance, more likely to respond to monetary incentives, more likely to talk to their physician 
about concerns for developing a disease, and less likely to have previously refused participation 
in a clinical trial.  These results indicate that women are more likely than men to seek health 
information that pertains to their family history, incentives act as a motivation for individuals to 
enroll in this database, and issues of distrust may still act as a barrier to research participation for 
African Americans.   
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 BACKGROUND 
 
 
The Center for Minority Health (CMH) created The Minority Research Recruitment Database in 
the spring of 2004.  The database stores family history information collected from individuals in 
the African American community.  The information is used to identify and contact minorities 
who may qualify for clinical research trials with the aim of increasing minority recruitment in 
research.  This study aims to compare various characteristics between individuals who elect to 
enroll in this database and those who decline enrollment.  Characteristics to be compared include 
demographics, recruitment variables, attitudes and beliefs towards research, health care 
information, personal health status, and family history.   
 
This research was conducted by the Center for Minority Health within the University of 
Pittsburgh, Graduate School of Public Health.  CMH was created in 1994 and has been under the 
leadership of Dr. Stephen B. Thomas since 2000.  The vision of the Center is to eliminate racial 
and ethnic disparities in health by the year 2010.  The work conducted within CMH includes 
health promotion and disease prevention activities, community-based research, health education 
and lay-health-advisory training, and information dissemination related to cultural competency, 
health communication, and health literacy.   In addition, seven national health disparity priority 
areas have been identified and are the focus of many of the Center’s efforts.  These priority areas 
include: cancer screening and management, cardiovascular disease, diabetes, HIV infection and 
AIDS, immunizations (adult and child), infant mortality, and mental health.   
1 
 INTRODUCTION 
 
The Center for Minority Health (CMH) has a mission to eliminate racial and ethnic health 
disparities.  Racial and ethnic disparities, according to the Department of Health and Human 
Services’ Office of Health Disparities, can be defined as a disproportionate burden of disease, 
injury, death, and disability within racial and ethnic minorities. [1] One specific aim is to provide 
family history risk assessments to the African American population of Pittsburgh, Pennsylvania.  
Individuals may also have their family health history entered into a computer database that 
provides them access to clinical trials for which they may enroll.  This approach is based upon 
the hypothesis that individuals who complete family health histories will demonstrate an increase 
in knowledge about family history and how it relates to disease and will be more willing to 
participate in clinical research.   
 
 In the following section, a literature review provides an overview of racial and ethnic health 
disparities that exist both on a national and local level.  Additionally, the review will describe the 
history of African Americans’ participation in clinical trials and the utility of family health 
histories.   
 
Racial and Ethnic Health Disparities 
 
As early as 1906, W.E.B. Du Bois authored The Health and Physique of the Negro American, 
one of the first known documents that focused on health disparities between black and whites. [2, 
3] Still today in the 21st century, African Americans and other minorities are disproportionately 
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 burdened by many chronic diseases when compared to whites, both on a national level and a 
local level in Pittsburgh, Pennsylvania.  This has a significant impact on our country considering 
that almost 25% of individuals are classified as minorities, according to the 2000 U.S. census.  
Within that 25%, about 12.3% reported being African American, which translates to almost 35 
million individuals.  At a local level, 12.4% of Allegheny County’s population self identified as 
African American, translating to almost 160,000 people as of the year 2000.  [4] 
  
The U.S. Department of Health and Human Services publishes data on trends in the health of 
Americans called Health, United States.  In 2002, the four leading causes of death for African 
Americans were heart disease, cancer, stroke, and diabetes.  Examining these four diseases in 
detail, the differences in mortality rates, incidence rates, and survival rates between African 
Americans and whites are significant.  The age-adjusted death rate for heart disease in 2002 was 
371.0 (deaths per 100,000 resident population) for Black males in comparison to 294.1 for white 
males and 263.2 for Black females in comparison to 192.1 for white females (See Table 1).  The 
age adjusted death rate for cancer in 2002 was 319.6 (deaths per 100,000 resident population) for 
Black males in comparison to 235.2 for white males and 190.3 for Black females versus 162.4 
for white females (See Table 1).  In regards to cancer rates in 2000, Blacks reported 506.2 new 
cases of cancer per 100,000 in the population versus whites who reported 469.7 new cases per 
100,000 individuals.  Also, five-year survival rates for all sites of cancer in 1992-1999 were 
lower in African Americans in comparison to whites: 53.3% versus 64.4% respectively.  Stroke 
death rates in 2002 were 81.7 (deaths per 100,000 resident population) for Black males compared 
to 54.2 for white males and 71.8 for Black females in comparison to 53.4 for white females (See 
Table 1).  Finally, in 1999-2000, 14.7% of the African-American population had diabetes in 
3 
 comparison to 7.4% of the white population, almost double the incidence.  As is evident by these 
recent statistics, health disparities between African Americans and Caucasians continue to exist 
within our country and encompass the diseases that most commonly affect the African American 
population. [5]  
 
Table 1- Age-adjusted Death Rates in 2002 (deaths per 100,000 resident population) 
Disease Black Males White Males Black Females White Females
Heart Disease 371.0 294.1 263.2 192.1
Cancer 319.6 235.2 190.3 162.4
Stroke 81.7 54.2 71.8 53.4
 
Evidence suggests that health care disparities between African-American and Caucasian 
populations exist in Pennsylvania as well.  Pennsylvania, as a whole, received a state health 
ranking of 25th in the country by the United Health Foundation in their 2004 report.  This 
ranking is determined by combining individual measures of personal behaviors, community 
environment, and health policies with the resultant health outcomes into a comprehensive report 
of the health of a state.  In addition, a variety of measures within this report look at health 
disparities within each individual state.  For instance, in Pennsylvania, the years of potential life 
lost (YPLL) before age 75 is 6,826 years per 100,000 people for whites in comparison to 14,525 
years per 100,000 people for blacks.  Another instance of health disparity uncovered in this 
report involves pregnant women receiving adequate prenatal care.  Nearly 74.4% of pregnant 
Caucasian women receive adequate care in comparison to 57.2% of pregnant African American 
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 women.  These are just two of many challenges that this report raises for the state of 
Pennsylvania. [6] 
 
Reports have also been written about the health status of Allegheny County (Pittsburgh).  In 
2003, the University Center for Social and Urban Research published, The State of Aging and 
Health in Pittsburgh and Allegheny County: May 2003.  This study surveyed 5,000 individuals 
over the age of 65 and reports on individuals’ self-assessments of health.  According to this 
report, large health disparities exist between blacks and whites in the prevalence of hypertension, 
diabetes, stroke, and cancer within Allegheny County.  The percentages of affected elderly 
blacks in comparison to affected elderly whites show evidence of health disparities: 66.8% vs. 
48.3% for hypertension, 11.2% vs. 9.6% for stroke, 27.7% vs. 16.6% for diabetes, and 5.6% vs. 
4.5% for all cancers. [7]  As previously mentioned, these are some of the leading causes of 
morbidity and mortality for African American’s across the country.   
  
In January of 2002, the Urban League of Pittsburgh and the University Center for Social and 
Urban Research released “The Black Papers”, a report that looked at the health status of African 
Americans of all ages in Allegheny County.  The four leading causes of death of blacks in 
Allegheny County were determined to be heart disease, cancer, stroke, and diabetes, the same 
leading causes of death for this population at a national level.  African American females, ages 
44-54, and African American males, ages 35-44, have three times the death rates for heart 
disease in comparison to whites.  The prostate cancer death rate is more than three times greater 
for African American males ages 65-74 in comparison to white males of the same age.  Overall 
cancer rates are 1.9 times greater for Blacks in men ages 45-54.  Diabetes death rates are about 
5 
 double for Blacks in comparison to whites, for both men and women.  Stroke death rates for 
African Americans are about 1.5 times that of Caucasians ages 65-74.  These health disparities 
within the Pittsburgh area reflect what is seen at both a state and national level.  [8]
 
Racial and ethnic health disparities are evident in both national and local statistics.  Many 
reasons have been postulated as to why blacks experience a disproportionate burden of morbidity 
and mortality when compared to whites.  African Americans tend to be of lower socioeconomic 
status, which is closely linked to poor health status.  In addition, blacks tend to have a greater 
exposure to psychosocial risk factors (such as unemployment and stress) as well as 
environmental risk factors (such as diet and high risk behaviors).  Finally, blacks are less likely 
to have health insurance, less likely to receive medical care, more likely to receive medical care 
of poorer quality, less likely to have access to continuous care, and less likely to have access to 
preventative care. [8, 9] These are just some of the possible factors contributing to the nationwide 
problem that has generated the urgency reflected in the national efforts to eliminate racial and 
ethnic health disparities.   
 
Recent federal legislation was passed entitled the Minority Health and Health Disparities 
Research and Education Act of 2000.  This Act called for the NIH to create the National Center 
on Minority Health and Health Disparities (NCMHD).  Its mission is to conduct and support 
research, training, and dissemination of information with respect to health disparities suffered by 
minority populations. [10] The NCMHD has funded several “Centers of Excellence” focused on 
the elimination of health disparities.  The Center for Minority Health at the University of 
Pittsburgh is one of these national sites.   
6 
 African Americans and Participation in Clinical Trials 
 
One of the recommendations for elimination of health disparities is to increase minority 
participation in clinical research.  Minorities have historically been underrepresented in clinical 
trials. [10, 11] The majority of studies fail to collect data on race and ethnicity or fail to report it.  
When this data is collected, it is often apparent that the proportion of minorities participating is 
underrepresented.  There are some areas of research in which the enrollment rate is especially 
lacking.  Cancer research, AIDS clinical trials, women’s health clinical trials, and psychiatric 
research have an especially low participation rate of ethnic minorities. [11] 
  
The low minority participation in clinical research is a problem given the wide range of health 
disparities.  As discussed previously, minorities have a higher prevalence of chronic conditions 
such as diabetes, certain cancers, and cardiovascular disease.  In addition, conditions exist, such 
as breast cancer, in which the incidence is lower within minority populations but the rates of 
morbidity and mortality are significantly higher. [11] By including ethnic minorities in clinical 
research, we are giving individuals access to new and high-quality health care, increasing our 
ability to generalize research, learning of any potential difference in the pathophysiology of the 
disease, and checking for any race-related differences in treatment responses. [11, 12]  Over 
sampling of certain racial subgroups may be the only way to assure adequate representation in 
clinical trials. [12] There is both promise and hope that by increasing minority participation in 
clinical research, science will discover the pathway to eliminate health disparities.     
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 Recently, race-related differences in drug responses have been reported in pharmaceutical trials.  
Responses to drugs can be affected by differences in absorption, metabolism, distribution, 
excretion, and in the presence of other drugs.  In some cases, these differences have been related 
to demographic characteristics, such as race. [13] While such findings may be controversial, it 
suggests that diverse study populations may be important in the development of new 
medications.  As early as 1929, differences in drug responses were reported between blacks and 
whites.  One of the more recent studies has shown that African American hypertensive patients 
repeatedly do not respond as well to antihypertensive β-blockers in comparison to white patients.  
Data suggest that race/ethnicity is a factor that should be considered when conducting and 
analyzing clinical drug trials.  Differences among groups suggest the need for active recruitment 
of diverse populations so that adequate information on drug response and efficacy can be 
obtained. [14] 
 
A study by Svensson (1989) looked at 50 drug clinical trials to examine the representation of 
African Americans.  Overall, 55% of drug studies included blacks.  About 13 of the 50 involved 
antihypertensive drugs.  Of these, only 8 included African American participants and only 1 
actually attempted to determine if there was a racial difference in drug response.  Several 
suggestions have been made to improve our understanding of racial differences in drug 
responses: 1) All clinical trials should attempt to describe the racial composition of their study 
population; 2) Pharmaceutical manufacturers should attempt to increase enrollment of blacks in 
their clinical drug trails; 3) Specific studies should be conducted to examine the influence of race 
on drug response in order to assess the effectiveness or safety of new drugs in members of 
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 minority groups. [15] The absence of this information will only limit the ability of patients to 
benefit from drug therapies. [14] 
 
It is important during drug development to include participants who represent the broad range of 
patients who will eventually receive the drug, including people of both genders, representatives 
of major racial/ethnic groups, and patients with a wide range of disease severity.  [13, 15] The 
FDA has modified the guidelines over the years to ensure the safety and efficacy of drugs by 
adequately studying them in individuals who represent the full range of patients who will receive 
them upon marketing.  The 1998 Guidelines for the Format and Content of the Clinical and 
Statistical Drug Applications requires that “analyses of effectiveness and safety data for 
important demographic subgroups, including race, be included in NDAs and that enrollment of 
subjects in clinical studies for drug and biological products be tabulated by important 
demographic subgroups in investigational new drug annual reports.” [13] 
 
The FDA is not the only organization working towards diversifying study populations in clinical 
trials.  In a national effort to increase minority recruitment, the NIH passed the Revitalization 
Act of 1993 in which guidelines were established to include women and minorities in research 
involving human subjects, including clinical trials.  These guidelines went into effect on March 
9th, 1994, and stated that the NIH “must 1) ensure that women and members of minorities and 
their subpopulations are included in all human subject research; 2) for Phase III clinical trails, 
ensure that woman and minorities and their subpopulations must be included such that vast 
analyses of differences in intervention effect can be accomplished; 3) not allow cost as an 
acceptable reason for excluding these groups; and 4) initiate programs and support outreach 
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 efforts to recruit these groups into clinical studies.” [10, 16] These guidelines were later amended 
in October of 2001 and incorporated four points: 1) the definition of clinical research was 
updated to patient-oriented research [research conducted with human subjects (or on material of 
human origin such as tissues, specimens, and cognitive phenomena) for which an investigator (or 
colleague) directly interacts with human subjects]; patient-oriented research includes 
mechanisms of human disease, therapeutic interventions, clinical trials, development of new 
technologies, epidemiologic and behavioral studies, outcomes research, and health services 
research; 2) racial and ethnic categories were updated in order to comply with the new standards 
issued by the Office of Management and Budget; the NIH is required to use these definitions to 
allow comparisons to other federal databases, especially the census and national health 
databases; 3) language governing NIH-defined Phase III clinical trials was clarified  in order to 
be consistent with the mandate for the inclusion of women and minorities as subjects in clinical 
research; the amended policy provides additional guidance on the analyses and reporting of 
analyses of sex/gender, racial/ethnic, and relevant subpopulation differences in intervention 
effects for NIH-defined Phase III clinical trials; and 4) roles and responsibilities of NIH staff and 
the extramural community were updated with regard to the implementation of the NIH policy on 
the inclusion of women and minorities as subjects in clinical research. [10, 17] To date, no 
further changes have been made to this policy.   
 
Despite detailed and increasing regulations to protect research participants, a large portion of the 
American population, particularly the African American population, continues to distrust 
physicians, medicine, and research. [18] Research has sought to provide explanations for the 
limited involvement in medical research. In addition to the distrust of the scientific community, 
10 
 other reasons addressed in the literature include socioeconomic constraints, language and literacy 
barriers, misunderstanding of research, fear of deportation, lack of access to medical care, 
physician concerns about referring patients, an inability to recruit minorities into such studies, as 
well as researcher and physician biases. [11, 19, 20]
 
Distrust of the scientific research community by ethnic minorities, especially blacks, is deeply 
rooted in American history and stems from past mistreatment.  For example, the history of 
slavery set the backdrop for distrust of authority figures and government leaders.  Blacks also 
tend to distrust the American health care system and health care providers in general.  African 
Americans tend to have more preventable hospitalizations and undergo fewer important 
diagnostic and therapeutic procedures.  Studies have shown an overall lower level of trust and 
satisfaction of physicians by ethnic minorities. [11] Finally, African Americans have a long 
history of being abused as research subjects, dating back to the time of slavery when they were 
used for medical experimentation.  One of the most blatant examples of research abuse was the 
Tuskegee Syphilis Study (1932-1972) in which poor black men were denied informed consent, 
were told procedures were therapeutic when in truth they were diagnostic, and were not given 
treatment for syphilis when it became available in the 1950’s.   This study is one of the more 
well-known examples of ethical misconduct in the context of clinical research, but other 
examples exist in which researchers failed to provide informed consent, withheld important 
information, changed the protocol without consulting individuals, and did not provide 
appropriate follow-up care. [11, 18, 20, 21] Given this history, it is understandable that African 
Americans and other ethnic minorities express distrust for the research community.   
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 A number of studies have been conducted to examine the current attitudes of minorities towards 
medical research. [11, 18] Studies find that minorities are afraid of being treated like “guinea 
pigs”.  These studies find that many African Americans think of research as unethical and that 
scientists are untrustworthy.  In addition, African Americans are more likely to think that 
researchers conceal information from participants and have little respect for participants in 
comparison to whites.  Overall, these results suggest that minorities harbor a general distrust of  
research and the research community.  [7, 11] 
 
In addition to clinical researchers, physicians are also distrusted by many African Americans.    
One study examined differences in distrust of physicians by race.  A national telephone 
questionnaire was conducted with a population of over 900 black (59%) and white (41%) 
participants.  African Americans were more likely than whites not to trust that their physician 
would fully explain research participation (41.7% vs. 23.4%); less likely to believe that they 
could freely ask their physician questions (15.2% vs. 7.6%); more likely to disagree that their 
physician would not ask them to participate in the research if the physician thought there was 
harm (37.2% vs. 19.7%); more likely to state that they thought their physicians sometimes 
exposed them to unnecessary risks (45.5% vs. 34.8%); more likely to believe that someone like 
them would be used as a “guinea pig” without his or her consent (79.2% vs. 51.9%); more likely 
to believe that physicians often prescribed medication as a way of experimenting on people 
without consent (62.8% vs. 38.4%); and more likely to think that their physicians had given them 
treatment as part of an experiment without their permission (24.5% vs. 8.3%).  These important 
differences by race in aspects of trusting physicians may influence reluctance to participate in 
clinical research. [18] 
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 In light of the overwhelming evidence that distrust is a major barrier to minority recruitment, 
many organizations have worked to rebuild trust with minority populations.  For example, the 
Resource Centers on Minority Aging Research (RCMAR) reported being successful in building 
trust within the African American community.  The researchers visited churches and spoke about 
their hopes of working together and how participation could benefit members of the community.  
They worked closely with well-respected leaders within the community.  Once they had their 
trust, these well-respected leaders endorsed the studies and talked to their congregations about 
the benefits of joining the study.  The researchers also built trust by helping with and 
participating in social events and providing clinical services within the community, thus 
developing a reciprocal partnership.  As a result of the relationships built, there was an increase 
in participation by minorities in several research studies.  In addition, they were able to maintain 
trust by sharing the research results.  Following RCMAR’s success, they published 
recommendations that can be adopted by other researchers for building trust and enhancing 
recruitment efforts (See Figure 1). [11, 19] 
 
RCMAR’s Recommendations: 
1. Develop relationships with trusted community members, leaders, and community-based efforts 
2. Recognize and incorporate the community’s cultural standards and health concerns 
3. Apply university resources during times of critical need 
4. Participate in the political process regarding health concerns 
5. Employ researchers and staff reflective of the community 
6. Practice beneficence 
7. Include community members in research development when possible 
8. Communicate research outcomes to study participants and their communities 
9. Provide incentives and reimbursements for participation 
10. Use appropriate language 
11. Elicit opinions from ethnic adults about their health priorities and solutions for overcoming 
participation barriers 
12. Teach researchers cross-cultural sensitivity 
13. Disseminate “best practices” for research recruitment and retention in academic forums 
Figure 1- RCMAR's Recommendations for Building Trust and Enhancing Recruitment [11] 
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 Following these guidelines will assist researchers in rebuilding trust and enhancing recruitment 
efforts.  However, rebuilding trust is not the sole solution.  Despite all of the research that finds 
trust to be a major barrier in minority recruitment, it would be misleading to suggest that it is the 
only barrier to participation in clinical trials.  Several authors suggest that the attitudes of 
researchers and physicians act as barriers towards minority recruitment.  Some researchers may 
limit minority recruitment due to a belief that minorities have lower rates of compliance and 
higher rates of attrition.  Some researchers claim that including minorities or women in their 
studies lower the statistical power of their study.  Others have low recruitment because they fail 
to establish research clinics in minority institutions.  Another barrier mentioned by researchers is 
that there is limited funding that can be spent on actively recruiting minorities. [20] This 
evidence suggests that we need to not only work with the target populations to increase 
recruitment, but also work with the physicians and researchers who are also potentially 
introducing barriers.    
 
Recruitment in the African American community needs to be an ongoing process of engagement, 
dialogue, and feedback. [18] A conference was held at Tuskegee in 1996 at which members of 
the local African American community met with community leaders, researchers, and health care 
providers to discuss minority recruitment issues.  The conference was set up in the format of 
presentations, focus groups, and interviews.  The African American community participants 
indicated during their focus group that they would be more likely to take part in research if they 
felt it was beneficial to their family or community and if it was supported by the church.  
Barriers to participation included time commitments, the collection of blood samples, the use of 
radiation, distrust, lack of information, and bad past experiences.  They recommended solutions 
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 to include workshops to provide more information about clinical trials, community education, 
utilizing churches, and using fraternities and sororities in recruitment efforts.  The community 
leader interviews conducted during the conference identified barriers to minority recruitment as 
well, which included the perception that insurance will not cover clinical trials, complexity of 
consent forms and the research trials, and distrust of the healthcare system.  The recommended 
strategies towards overcoming these barriers included making the project more accessible to 
participants, writing easy-to-read consent forms, scheduling study activities during nonworking 
hours, and using recruiters known within the study community.  Finally, health care provider 
interviews revealed reasons for not referring minorities to clinical trials such as skepticism about 
the capability of low-income minorities to participate; concerns that their patients would be 
randomized to a control group; and fear that their patients would be “stolen away.”  They 
proposed solutions to these problems including the development of educational programs for 
community physicians and the involvement of providers in prevention trials.  At the conclusion 
of this conference, two themes emerged.  The first theme involved the critical need to involve the 
community in the research process from the beginning.  The second theme was the importance of 
researchers and community members having open dialogue. [22] 
 
A similar study was conducted by Freimuth et. al. (2001).  This study consisted of seven focus 
groups with 60 African Americans in 4 cities across the United States.  This study was designed 
to examine knowledge and attitudes towards medical research as well as knowledge of the 
Tuskegee Syphilis Study.  The study showed that participants had a limited understanding of 
various aspects of research and concluded that the presence of misconceptions may have an 
impact on participation.  For example, few of the participants could clearly define common 
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 research terms, such as confidentiality, informed consent, placebo, clinical trial, protocol, and 
randomization.  Participants indicated that they had difficultly giving informed consent due to 
the complexity of the research.  Few participants had ever participated in research and 
participants had trouble making the distinction between treatment, prevention, and research.  In 
addition, several participants questioned the likelihood that African Americans would benefit 
from research.  Upon completion of the study, it was concluded that a crucial first step in 
increasing minority recruitment is educating the public to have a clear understanding of research, 
its terms and procedures, and its many purposes. [20]
  
The extensive research conducted on the topic of minority participation in clinical trials indicates 
that increasing minority recruitment is not going to be an easy task.  African American 
participants need to have a better understand of research in general.  More attention must be 
given to building trust between blacks and researchers as well as with the health care community.  
Also, racial biases in attitudes and opinions of researchers that act as barriers towards 
recruitment need to be addressed.  Most importantly, all of these issues need to be openly 
discussed between the African American community, the research community, and the health 
care community in order to achieve a solution to the problem of minority recruitment.  
 
Family History and Public Health 
 
As previously discussed, African Americans and other minorities are at an increased risk for 
developing common chronic diseases, such as heart disease, diabetes and cancer.  According to 
the American Heart Association, these conditions are among the leading causes of morbidity and 
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 mortality in the United States and other developed counties. [23] In addition, causes for these 
diseases are multifactorial, meaning that they are the result of multiple gene and environmental 
interactions. [24, 25] While these interactions are complex and still not completely understood, 
the family health history is a valuable tool that is able to capture the relationship between genetic 
susceptibilities, common behaviors, and shared environment. [24, 26, 27] 
 
One of the most effective tools for recognizing an individual’s risk for diseases with a genetic 
component is the analysis of his or her family health history, or pedigree. [25] The pedigree has 
long been a critical element in clinical genetics visit.  It aids in making a diagnosis, determining 
risk, and assessing the need for patient education and providing psychosocial support.  [25, 28] 
Genetic medicine has recently entered the realm of primary care. [25] It is estimated that 45% of 
families have a positive family history of one or more common chronic disease. [29] The family 
health  history has been shown to predict the risk of many of these conditions, including heart 
disease [24, 27, 29, 30], colon cancer [24, 30], breast cancer [24, 30], ovarian cancer [24, 30], 
osteoporosis [24, 27], asthma [24, 27, 30], adult-onset diabetes mellitus [24, 27, 30, 31], and 
suicide[24]. Also, early cardiovascular-related events, such as coronary heart disease, stroke, 
hypertension, and diabetes, occur more frequently in families with a positive history of 
cardiovascular disease. [27] In general, a family history of a common, chronic disease is 
associated with relative risks ranging from 2 to 5 times greater than those of the general 
population. [23, 27]  Therefore, the family health history has the potential to be a cost-effective, 
population-based screening tool for genetic risk of common diseases.[25]   
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 Assessment of family history has been used in a few instances as a public health screening tool 
for a specific disease.  One such example in the literature involves using family history as a 
population-based screening tool to identify individuals and families who were at high risk for 
cardiovascular disease (CVD).  Two general approaches to primary prevention of CVD have 
been proposed: population-wide health promotion and targeted intervention in high-risk groups.  
Population-based educational programs have been instrumental in reducing CVD incidence.  In 
addition, prevention methods have consisted of targeting high-risk individuals who can be 
offered more intensive intervention than the general population.  A high school-based Health 
Family Tree Study in Utah successfully used family history to evaluate risk of CVD.  Overall, 
14% of Utah families had a positive family history of CVD.  However, these families accounted 
for 72% of all early heart disease events and 48% of events at any age.  These results 
demonstrate that early events of heart disease cluster in families with a positive family history 
and that these families might benefit from rigorous intervention. [29] 
  
The potential usefulness of the family health history has also been demonstrated in the case of 
identifying individuals who are high-risk for diabetes.  It has been suggested that a large 
percentage (33%-50%) of individuals with Type 2 diabetes are undiagnosed and untreated, 
translating to about 8 million people.  Furthermore, many people with diabetes will already have 
complications associated with the disease prior to the time of diagnosis.  There is a need to 
identify individuals at high risk for developing the disease and encourage behavior modification 
that could result in disease prevention. [32]   Knowler et. al (2002) performed a study on 3234 
non-diabetic individuals in which people were randomly assigned to one of three groups: 
placebo, metformin (850mg, 2x a day), or lifestyle modification (consisting of weight-loss and 
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 increased physical activity.)  The lifestyle intervention reduced the incidence by 58% whereas 
the metformin reduced the incidence by 31%. [33]  Results of this and other similar studies have 
lead the American Diabetes Association to issue a position statement that states that lifestyle 
modifications including healthy diet, increased physical activity, or pharmacologic interventions 
can significantly decrease the incidence of diabetes in high-risk groups.  This evidence suggests 
that it is possible to delay the onset of diabetes.[32] Therefore, it is essential to identify high-risk 
individuals who would benefit from targeted interventions.   
 
Family history has been shown to be a key tool in identifying individuals at risk for developing 
diabetes.  There is a two-fold to six-fold increased risk for Type 2 diabetes when there is a family 
history.  The risk is found to be elevated across various study designs and ethnic groups.  It has 
been suggested that once individuals are aware of the increased risk, they are more likely to 
partake in risk-reduction behaviors. [32] One study of 1112 participants found that individuals 
with a positive family history (39%) were 45% more likely to report having a diabetes screening 
in the past year over individuals without a family history (61%). [34] This evidence indicates that 
family history information can be useful in identifying individuals at high risk for disease who 
then may be more likely to participate in appropriate interventions.  
   
Research suggests that family history by itself is most useful for predicting disease when 
multiple family members are affected, when family members are closely related, and when 
individuals are diagnosed with early-onset disease. [27]     Research has aimed to identify the 
accuracy of family history information reported by individuals.  In a case-control study, the 
authors reported that histories of first-degree relatives were validated using death certificates, 
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 physician records, and hospital records.  In the 174 cases examined, the sensitivity, positive 
predictive value, and specificity were 67.3%, 70.5%, and 96.5% respectively.  The lower 
sensitivity values indicate some under-reporting of disease in relatives. [23]   Another study 
examined the accuracy of patient reports of a family history of cancer.  The accuracy of cancer-
site identification by the participant was 83.7%, and about 71% in first and second-degree 
relatives. [23]   Overall, these studies suggest that a positive family history report can generally 
be used with a high degree of accuracy.  
 
Family history information can be a valuable tool in disease prevention.  However, collection 
and interpretation of this information is rarely used in public health practice or preventative 
medicine as a means to assess disease risk and design methods for early detection and preventive 
strategies. [27-29] Henderson and Scheuner (1998) performed a study that examined 15 primary 
care physicians to determine how family history information was collected and recorded during 
regular primary care visits.  The study found that of all the patients that reported a positive 
family history for at least one common disease, the physician only recorded the family health 
history 36% of the time. [27] A study by Acheson (2000) found that physicians only discuss 
family history information about half of the time during new patient visits.  This percentage 
decreased to 22% in established patient visits.  When physicians did take the time to discuss 
family history information, the average duration of the discussion was less than 2.5 minutes.  
When the physician’s charts were reviewed, only 11% contained some sort of family health 
history. [27, 35] It appears that family history information is lacking as a routine screening tool 
in primary care settings.    
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 A variety of reasons have been proposed to explain why family history information has not been 
used effectively by health professionals.  For example, Guttmacher believes that clinicians 
commonly underestimate the immense value of family history information.  Many physicians 
find it difficult to find the time to obtain, organize, and analyze family history information. [24] 
Also, many physicians report that they have had little training in genetics, they feel 
uncomfortable providing genetic counseling, and are wary of interpreting genetic test results. 
[23, 25] In a study that looked at traits of physicians who utilized family history information, 
physicians with fewer years of practice were more likely to take family health histories.  Also, 
physicians with greater knowledge of genetics were more likely to provide risk assessments 
based upon family history information.  Finally, physicians who had a higher rate of preventive 
service delivery were more likely to discuss and record family history information. [35] 
 
A study conducted by Suchard et. al. (1999) examined the attitudes of 339 general practitioners 
to determine their use of family health histories.  Approximately 60% of practitioners agreed or 
strongly agreed that they should be involved with screenings for common diseases.  However, 
only 29% of respondents reported that they were adequately prepared to take a family health 
history.  This shows that while health professionals may understand the utility of family health 
histories, there is a drastic need for educating health professionals and helping them to feel 
comfortable in recording and interpreting family history information.  However, it is promising 
that 78% of respondents wanted to learn more about genetic screenings. [36]  
 
While physicians may or may not recognize the benefit of family history information, the general 
public tends to think that it is useful.  A recent questionnaire of over 4000 individuals was 
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 conducted to analyze public opinion on family history information.  The authors reported that 
73% of individuals felt that knowledge of family history information was very important and an 
additional 24% of people felt that this information was somewhat important.  Despite this, only 
30% of respondents indicated that they had actually collected family history information. [24]   
 
It appears that the general public and physicians would both benefit from family history 
information in health promotion and disease prevention.   Failure to recognize a positive family 
history could lead to detrimental health effects.  For example, many women are unaware that a 
family history of breast/ovarian cancer in their father’s family may warrant increased cancer 
screenings.  If their physician never takes their family health history, women may not be 
involved in proper surveillance. [24] Individuals who have a genetic susceptibility to a condition 
such as hereditary breast and ovarian cancer can often benefit from enhanced screening protocols 
that involve more intense screening methods, beginning at earlier ages, and occurring more 
frequently. [23, 26]  For example, women at greater risk for breast and ovarian cancer are 
recommended to have annual mammograms beginning as early as 25 in comparison to the 
general population’s recommendation of beginning at age 40. They are also recommended to 
have monthly self breast exams starting at ages 18-21 and semiannual clinical breast exams 
starting at ages 25-35.  In order to reduce their ovarian cancer risk, screening tests such as semi-
annual CA-125 blood tests and semi-annual transvaginal ultrasounds are also available.  These 
ovarian screening tests are not routinely offered to the general population. [37]   
 
Screenings are not the only way for high-risk individuals to reduce their risk.  Many conditions 
have behavior-modification strategies that have been demonstrated to prevent disease or delay 
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 onset. [24, 26] For example, the risk for developing diabetes or coronary artery disease can be 
decreased by making modifications in lifestyle behaviors and diet.  When a clinician is unaware 
of a positive family history for one of these conditions, relevant behavior modifications may 
never be recommended and may never take place. [24] Some individuals may benefit from 
chemoprevention, or taking medications that lower their risk.  A physician would not recognize 
the need to prescribe these medications without knowing that their patients are at risk. Finally, 
some family histories may direct a physician to refer the patient to a specialist that can best 
manage a patient’s risk for a particular condition. [26]  Noting a family history early could allow 
a patient to benefit from the expertise of a specialist who could educate the patient about possible 
preventative measures.  There are compelling reasons to routinely collect family history 
information for each individual patient.     
 
Measures need to be taken to increase the effectiveness and use of the family health history.  The 
first step is to educate both the public and health care professionals about the value of the family 
health history.  In addition, a method for collecting and analyzing this information that makes the 
task easy and time-efficient for the clinician is needed. [24] Once an individual is identified as 
being at increased risk, the clinician would have the opportunity to counsel a patient about 
lifestyle changes and screening techniques for risk reduction.  While each individual reacts 
differently upon learning about his or her risk, some studies suggest that individuals are more 
likely to comply with preventive recommendations once they have this information. [25] 
Prevention efforts that would be cost-prohibitive in the general population could prove to be 
cost-effective when they are targeted towards high-risk individuals. [27] 
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 The U.S. Surgeon General has developed a Family History Initiative with the goal to increase 
awareness of the importance of family history and to provide a tool that collects and organizes 
family history information.  Thanksgiving Day has been designated as the annual National 
Family History Day in order to increase communication about family health issues among family 
members.  A web-based tool (www.hhs.gov/familyhistory) that allows individuals to organize 
and store their family history information is available.  In addition, individuals can easily access 
this information and update their family health histories over time as their situation changes.  
This tool also highlights conditions in which known medical recommendation exist.  These 
conditions include breast cancer, ovarian cancer, colon cancer, stroke, diabetes, and coronary 
artery disease. [24] 
 
People should be encouraged to collect family history information.  Having families put together 
this information can enhance their awareness of shared disease risk and can provide an 
opportunity for family-based lifestyle changes. Encouraging individuals to collect family history 
information may prove to be a beneficial public health prevention tool. [29] 
 
Until we have genetic tests that identify susceptibility genes and a way to measure environmental 
exposures, family history information that reflects both genetic and environmental factors may 
be an effective means for predicting risk for future disease. [27] A comprehensive family health 
history that includes information regarding common, chronic disease of adulthood should be an 
integral component of any disease prevention program.  This technique is a comprehensive and 
generally accurate method for risk stratification for many preventable conditions that impact a 
large percentage of the general population as well as the African American population.  
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 Individuals identified in this manner have the most to gain from targeted preventive 
interventions. [23]   
 
Family history information can be recorded graphically in the form of a family health history, or 
pedigree, which is a quick visual tool for incorporating and interpreting medical information.  
Key information recoded for each individual in a pedigree includes age, age of death, cause of 
death, siblings (denote if half or full), children (note if with separate partners), parents and 
grandparents, aunts, uncles, cousins, age at diagnosis, ethnic background for all grandparents, 
and consanguinity. [26, 38] It is important to record this information so that both the presence of 
a family history that confers risk and a family history that does not can be noted.  In addition, 
this graphical form of a health history shows the exact relationship of relatives and can be critical 
in making a diagnosis or assessing risk.  A pedigree can also be used as a visual tool for 
assessing the medical, emotional, and social impact of a disorder on the patient and the entire 
family.  In addition, a pedigree is a valuable tool for patient education because it is a visual 
representation of their entire family.  These are just some of the many benefits of a pedigree that 
make it an ideal method for identifying individuals at risk for common disease and helping 
individuals to understand their risk (See Figure 2). [38]  
 
There is a clear role for public health professionals to incorporate family health histories into 
community outreach activities.  As previously discussed, the systematic use of family health 
histories in public health and preventative medicine is largely neglected. [39] It is possible that if 
family health histories made their way into general practice, general practitioners could utilize 
the benefits of a family health history and provide genetic screenings for common diseases.   
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 Uses of a Pedigree [38]: 
• Developing a differential diagnosis 
• Identifying genetic and environmental risk factors for disease 
• Establishing a pattern of inheritance for genetic counseling and risk assessment 
• Identifying medical risks for other relatives 
• Deciding an approach to genetic testing 
• Planning medical management, prevention, and surveillance 
• Assessing reproductive options 
• Developing patient rapport and trust 
• Recording a snapshot of family’s health-related experiences 
• Seeing family dynamics: sources of conflict or support 
• Patient education; clarifying misconceptions 
Figure 2- Uses of a Pedigree  
 
Their roles could include making initial contact with concerned patients, taking family health 
histories to assess risk, referring patients for genetic testing and counseling, and providing 
patients with information about their personal risk. [36]  The benefits of family history 
information led to the development of the Healthy Black Family Project within the University of 
Pittsburgh’s Center for Minority Health.   
 
The Center for Minority Health has incorporated the family health history into community 
outreach programs focused on African Americans.  One issue that is not widely found in the 
literature is the importance of taking family history information in a culturally appropriate 
manner when screening for common disease.  Culture, in general, shapes the way each of us 
thinks and as a result, culture is deeply ingrained in many belief systems, including beliefs 
dealing with health. [40] Therefore, ethnocultural considerations must be taken into account 
when using family history information as a population-based screening and prevention tool.  
Since African Americans are at increased risk for common diseases, they are an important 
population to consider when developing these family history tools.  Culturally appropriate tools 
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 needs to take into account cultural variation by disease susceptibility, healthcare access, disease 
definition, risk estimation, and lifestyle behaviors. [32] 
 
The Center for Minority Health and the Healthy Black Family Project aim to reach out to the 
African American community in a culturally-competent fashion to provide individuals with 
knowledge that emerges from their family health history.   In addition to the benefit of having 
this knowledge, individuals have the opportunity to have their family health history entered into 
a research database and to be sent information about clinical trials.   
 
The present study aims to characterize individuals who completed a family health history and 
describe factors associated with a willingness to enroll in the Minority Research Recruitment 
Database.
27 
 METHODS AND PROCEDURES 
 
 
Healthy Black Family Project 
 
The Healthy Black Family Project (HBFP) is a comprehensive community-based intervention 
designed to promote health and prevent disease.  The HBFP is focused on a geographic area 
called the Health Empowerment Zone (HEZ): East End neighborhoods, including – East Hills, 
East Liberty, Homewood North, Homewood South, Homewood West, Larimer, Lincoln Larimer, 
and Wilkinsburg (See Figure 3).  These areas of Pittsburgh have an average of 79.1% African 
American residents and an average of 25.7% of residents living below the federal poverty line.  
The Family Health History is one of the innovative methods used to engage the community.     
 
Zip Code Neighborhoods 
15147 Penn Hills 
15206 Lincoln, Lemington, Belmar, East Liberty, Larimer, Garfield 
15207 Glen Hazel 
15208 Point Breeze North, Homewood South, Homewood North, Homewood West 
15213 Terrace Village, Upper Hill 
15219 Crawford Roberts, Terrace Village, Middle Hill, Bedford Dwellings, Upper Hill 
15221 Homewood North, East Hills, Wilkinsburg 
15224 Garfield 
Figure 3- The Health Empowerment Zone: Zip Codes and Neighborhoods 
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 Family Health History Initiative 
 
The Family Health History component of the HBFP sends genetic counseling graduate students 
from the University of Pittsburgh, Graduate School of Public Health, Department of Human 
Genetics, to African American churches, retirement centers, health/community fairs, and 
barbershops/salons within the HEZ.  Interested individuals are able to inquire about the family 
health history process at the HBFP information table.  Students then meet with individuals for a 
one-on-one session, lasting from 30 minutes to one hour.  The individual’s detailed family health 
history, or pedigree, is recoded by hand.  Once the pedigree is complete, the student provides a 
general risk assessment, often focusing on common, chronic diseases that the individual may be 
at increased risk for developing, based upon their family health history.  The student then 
provides the individual with information on relevant behavior modifications that may reduce 
their risk.  The student also emphasizes the importance of sharing this information with other 
family members and with his or her physician.  After the one-on-one family health history 
session, the student uses the hand-drawn family health history to create a computer-generated 
version of the pedigree using Progeny® software.  This document is sent to the participant along 
with targeted health education materials and a certificate of appreciation (See Appendix F).  
 
The Minority Research Recruitment Database 
 
Individuals who complete their family health history are given the opportunity to enroll in The 
Minority Research Recruitment Database, created by the Center for Minority Health as one effort 
to increase minority recruitment into clinical research trials.  By giving informed consent and 
enrolling into the database, the individual’s pedigree is stored in Progeny®.  As CMH becomes 
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 aware of a clinical study that is currently recruiting individuals, the database is queried for 
people who many meet the inclusion criteria.  Individuals who are identified are then sent 
information about the details of the study along with the investigator’s contact information.  
Contact information is kept entirely within the database and is at no time released to any study 
investigators.   
 
Assessing African American’s Response to Family Health Histories 
 
The purpose of this study was to assess the response of African Americans to Family Health 
Histories.  This study was funded by a grant to Stephen B. Thomas from the National Institutes 
of Health: National Center on Minority Health and Health Disparities, and received approval by 
the University of Pittsburgh Institutional Board of Review (IRB) in May of 2004 (See Appendix 
B).  The specific aims of the study were to: 1) describe the extent to which individuals with a 
family history of a particular condition demonstrate higher levels of awareness regarding their 
increased risk compared to individuals without a family history of that condition, 2) describe the 
extent to which knowledge of a personalized family health history shapes “information seeking” 
and other behaviors associated with health promotion and disease prevention, 3) describe the 
extent to which knowledge of a personalized family health history, including review of the 
pedigree, shapes willingness to participate in research, and 4) compare and contrast 
demographics, recruitment variables, health care information, family health, personal health 
status,  and opinions about research between individuals who agree to enroll in the Minority 
Research Recruitment Database to individuals who decline participation.   
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 The overall study was organized into two smaller studies designed to serve as Master’s thesis 
projects for two graduate students.  This thesis will focus on the 4th specific aim related to 
willingness to enroll in the database.   
 
Procedure 
 
All individuals who agreed to a family health history session were offered the opportunity to 
participate in this study.  If they expressed interest, the student reviewed the informed consent 
with the participant, explaining the aims, process, risks, and benefits of the study.  If participants 
remained interested, they signed the informed consent.  Also, they were asked if they were 
interested in enrolling in the Minority Research Recruitment Database.  The database was 
explained to be a method in which their family health history would be stored and queried and 
that they may be contacted with information about clinical trials for which they may qualify, 
based upon family history information.  If individuals were interested in enrolling, they signed 
the portion of the consent form that enrolled them into the database.     
 
Once the consent process was complete, they were asked to answer the pre-questionnaire.  This 
questionnaire consisted of demographic questions and questions about risk perception (See 
Appendix C).  Once they completed the initial questionnaire, the student took their family health 
history, eliciting as many generations as possible based upon the participant’s memory.  Once the 
family health history was completed and a risk assessment was provided to the participant, they 
were asked to complete the post-questionnaire.  This questionnaire consisted of risk perception 
questions, questions about individuals’ opinions on research, and questions about a research 
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 recruitment database (See Appendix D).  Finally, individuals were asked to give permission to be 
contacted in one month to have a short follow-up phone interview (See Appendix E).   
 
Pre- and Post- Questionnaires 
 
The questions used for this study included the demographic questions from the pre-questionnaire 
and the questions about attitudes and beliefs towards research, the research recruitment database, 
and post-session risk perception.  The majority of demographic questions and all of the questions 
about research opinions came directly from a study completed by S. B. Thomas, et. al [41].  This 
study assessed the influence of demographic variables on willingness to participate in a medical 
research study. The results of this study were directly reported to the Centers for Disease Control 
and Prevention (CDC).  In addition, the results of this study were reported in the Archives of 
Internal Medicine in 2002. [18] In regards to the remaining questions used in this study, they 
were created through the collaborative efforts of the Healthy Black Family research team. 
 
Pre-questionnaire – Section 1: General Information
Section 1 of the pre-questionnaire asked respondents to disclose demographic information and 
health care information.  Respondents were asked about their age, gender, race/ethnicity, total 
household income, level of education, knowledge of genetics, description of their general health, 
whether they have a primary health care provider, whether they have had difficultly going to a 
physician due to cost, health insurance status, whether they are currently concerned about 
developing a condition, to rate their worry for developing that condition, and whether they have 
spoken with a health professional about their concern for developing that condition.   
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Post-questionnaire – Section 1: Risk Perception 
Section 1 of the post-questionnaire asked individuals to rate their risk (Low, Moderate, and 
High) for the following conditions: breast cancer, ovarian cancer (females only), colon cancer, 
prostate cancer (males only), cardiovascular disease, lung cancer, diabetes, Alzheimer’s disease, 
and hypertension.  In addition, they were asked to rate their risk in comparison to individuals of 
the same gender and age as them for the same conditions mentioned above.  They rated their 
comparative risk on a scale from 1 (much lower) to 5 (much higher).   
 
Post-questionnaire – Section 2: Opinions on Research 
Section 2 of the post-questionnaire asked participants a variety of different questions regarding 
their opinions on research as well as their opinions on a database comparable to the Minority 
Research Recruitment Database.  They were asked how important they felt medical research 
was, if they have ever participated in medical research, whether they have ever declined an 
opportunity to participate in medical research, and their general attitude towards medical 
research that uses human subjects.  They were then asked how the following factors would affect 
the likelihood that they would agree to participate in clinical research: free medical care, $500, 
and free medicine.  They were then asked how much they felt the following groups of 
individuals benefit from medical research: scientists, their community, their family and friends, 
and them (as individuals).  The last group of questions on the post-questionnaire asked 
individuals to think about a database such as the Minority Research Recruitment Database and to 
indicate if they would have interest in entering such a database (Note: This is not where 
individuals enrolled in the database – they could only enroll by giving consent during the 
33 
 informed consent process).  If individuals indicated that they were interested, they were asked to 
answer a question in which they gave their expectations for such a database.  Individuals who 
were not interested in enrollment were asked to answer a question in which they gave reasons for 
declining.  Finally, participants were asked to describe their overall experience of having their 
family health history taken.   
 
Pedigree Analysis 
 
In the American Journal of Medical Genetics, Scheuner et al. (1997) established general 
guidelines for risk stratification for many common diseases, based upon family history 
information.  These guidelines use number of affected relatives, degree of relatedness, and age of 
onset to place individuals at average (population) risk, moderate risk, or high risk.   These 
guidelines apply to heart disease, stroke, diabetes, colon cancer, prostate cancer, breast cancer, 
ovarian cancer, and endometrial cancer [23] (See Figure 2 below).  Using these criteria, each 
pedigree was analyzed for all of these conditions and each individual was placed at average, 
moderate, or high risk, based upon their family health history.  Personal history was not used for 
risk stratification but was ascertained for heart disease, stroke, diabetes, colon cancer, breast 
cancer, ovarian cancer, endometrial cancer, Alzheimer’s disease, hypertension, mental illness, 
and substance abuse (including alcoholism).  We also examined each family for Alzheimer’s 
disease and hypertension using Scheuner’s stratification guidelines.  We defined premature age 
of onset Alzheimer’s disease to be ≤ 65 (given information identified on the Alzheimer’s 
Association’s website at http://www.alz.org/Resources/FactSheets/FSonset.pdf) and premature 
hypertension to be ≤ 50 (no distinct guideline was identified so we chose 50 to be conservative).  
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 We also noted whether any individual reported having two or more 1st or 2nd degree relatives 
with mental illness of any kind or substance abuse (including alcoholism).  Each pedigree was 
analyzed independently by two genetic counseling students.  Once each pedigree was analyzed 
for personal history and family history, the two counseling students compared results.  Any 
discrepancies were reanalyzed by three genetic counseling students in order to establish an 
agreed upon conclusion. 
 
Guidelines for Risk Stratification [23] 
High Risk Moderate Risk Average Risk 
1. Premature disease* in a 1st degree relative 
2. Premature disease* in a 2nd degree relative 
(coronary artery disease only) 
3. Two affected 1st degree relatives 
4. A 1st degree relative with late/unknown onset of 
disease and an affected 2nd degree relative with 
premature disease* from the same lineage 
5. Two 2nd degree maternal or paternal relatives 
with at least one having premature onset of 
disease* 
6. Three or more affected maternal or paternal 
relatives 
7. The presence of a “moderate risk” family 
history on both sides of the pedigree 
1. A 1st degree 
relative with late or 
unknown disease 
onset 
2. Two 2nd degree 
relatives from the 
same lineage with 
late or unknown 
disease onset 
1. No affected 
relatives 
2. Only one affected 
2nd degree relative 
from one of both 
sides of the pedigree 
3. No known family 
history 
4. Adopted 
individual with 
unknown family 
history 
*Premature disease: coronary artery disease onset ≤55 yrs in males, ≤65 yrs in females; stroke, 
noninsulin-dependent diabetes, colon and prostate cancer onset ≤50 yrs; breast, ovarian, and 
endometrial cancer onset premenopausal or ≤50 yrs. 
Figure 4 - Scheuner’s General Guidelines for Risk Stratification  
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 Extrapolated Data 
 
 
A portion of data used for analysis were collected through pedigree analysis.  It was determined 
which individuals reported suffering from at least one chronic condition as well as how many 
conditions each individual reported having.  It was also determined which individuals were 
considered high-risk for at least one condition, based upon their family health history.  In 
addition, the number of high-risk conditions, based upon their family health history, was 
tabulated for each individual.  Similarly, data were collected on which individuals perceived 
themselves at high risk on the questionnaire for at least one condition.  The number of conditions 
for which they considered themselves to be at high-risk was also tabulated.  Finally, a 
comparison was made between individuals’ perceived risk from the questionnaire to their actual 
risk based upon their family health history.  By making this comparison, the number of 
conditions that each individual over-estimated their risk, under-estimated their risk, and 
accurately estimated their risk was determined.  These data were entered into an Excel 
spreadsheet for the first phase of the data analysis.   
 
Data Analysis 
 
Each pre- and post-questionnaire was entered into an online version of the questionnaire using 
QuestionnaireSolutions®.  The questionnaire data were then exported into an Excel® file.  All of 
the data in excel were checked against the original questionnaires to correct for any errors made 
in entering the responses into the online version of the questionnaire.  The family history risk 
information and the personal history information (from the pedigree analysis) were then added 
into the spreadsheet.   
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Once all of the data were entered into the spreadsheet, it was decided that only data on African 
American participants would be analyzed.  Non-African American individuals were excluded 
due to their small representation of the total study population (4 individuals out of 130).  The 
participants were then divided into two groups: those who elected to enroll in the database and 
those who declined enrollment.  Once they were divided into their respective groups, the data 
were tabulated using Excel.  R® Statistical Package [42] was used to complete Binomial tests of 
proportions [43-45] and Fisher’s exact tests [46, 47] to determine significant differences between 
the group of individuals who enrolled in the database and those who declined enrollment.  
 
Whenever the analysis involved two variables (i.e. male vs. female), a binomial test of 
proportions was used.  This statistical analysis compares observed proportions using binomial 
probability for expectation. [43-45] 
Z=                      │p2 – p1 │                 . 
                                                          (((p1q1)/(n1))+((p2q2)/(n2)))1/2 
 
Whenever the analysis involved three or more variables (i.e. average risk vs. moderate risk vs. 
high risk), a Fisher’s exact test was used.   This statistical analysis consists of evaluating the 
probability of the observation table and comparing it to the probability for all other simulated 
tables with similar marginal counts. [46, 47] 
 
Pr=        (n1.!)(n2.!)(n.1!)(n.2!)         .                      
     (n..!)(n11!)(n12!)(n21!)(n22!)
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RESULTS 
 
 
During this study, 175 individuals completed their family health history with a genetic 
counseling student.  Of these individuals, a total of 126 (72%) African Americans agreed to 
complete the pre- and post-questionnaire during their family health history session.  For each 
participant, extensive information was collected on multiple generations within the family.  
Information was collected on a total of 4491 individuals.  The average pedigree size was 36 
individuals.     The most common conditions reported included hypertension, diabetes, cancers, 
heart disease, stroke, mental illness, and substance abuse.   
 
Among the 126 participants who participated in the study, 100 (79.4%) elected to enroll in the 
Minority Research Recruitment Database and 26 (20.6%) declined enrollment.  Data analysis 
compared selected variables between individuals who enrolled in the database to those who 
declined enrollment.  Information compared included demographics, recruitment variables, 
health care, attitudes and beliefs regarding research, personal health status, and family history.   
 
Demographics of the Study Population 
 
Demographic information collected included the participants’ gender, age, race/ethnicity, income 
level, and education.  These data were collected to ascertain any possible significant differences 
in demographics between the individuals who enrolled in the database and those who declined 
enrollment.  In addition to this information, individuals were asked to rate their knowledge of 
genetics.  
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 Basic demographic characteristics were analyzed for all study participants.  There was a 
significant difference between the gender distribution in the participants who elected to be 
enrolled in the database and the individuals who declined enrollment (See Table 5 in Appendix 
A).  Men were more likely to decline enrollment when compared to women (P=.038).  The 
distribution of race/ethnicity, age, income level, education, and knowledge of genetics were not 
significantly different between individuals who enrolled in the database and those who did not 
(See Table 2 and Tables 6-10 in Appendix A).  
 
Participant’s Family Health History Session 
 
Each participant completed a family health history session.  There were three different genetic 
counseling students who conducted the sessions and there were a variety of locations for 
participant recruitment.  Both of these variables were examined to detect possible correlations 
with the participants’ willingness to enroll in the database.  In addition, each participant was 
asked on the questionnaire to describe their experience of having their family health history 
completed as being enjoyable, informative, uncomfortable, and/or no opinion, and to choose all 
answers that applied.   
 
The participant’s likeliness to enroll in the database was not correlated with the student who 
completed the family health history session (See Table 11 in Appendix A).   However, there did 
appear to be a correlation between enrollment in the database and location of recruitment.  While 
the majority of individuals from both groups were recruited in a church, there was a much wider 
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 Table 2 - Comparisons of Proportions for Demographic Information 
Demographic Variable Enrolled in Database % (n) 
Declined Enrollment 
 % (n) 
Age 
      18-35 
      36-50 
      51-65 
      66+ 
 
13% (13) 
41% (41) 
33% (33) 
13% (13) 
 
15.4% (4) 
38.5% (10) 
34.6% (9) 
11.5% (3) 
Gender* 
      Female  
      Male 
 
82% (82) 
18% (18) 
 
65.4% (17) 
34.6% (9) 
Race 
      African American Only 
      African American and Other 
 
91% (91) 
9% (9) 
 
92.3% (24) 
7.7% (2) 
Income Level 
      <$10,000 
      $10,001-$20,000 
      $20,001-$35,000 
      $35,001-$50,000 
      $40,001-$75,000 
      >$75,001 
 
4.1% (4) 
17.5% (17) 
25.8% (25) 
18.6% (18) 
13.4% (13) 
20.6% (20) 
 
8% (2) 
16% (4) 
20% (5) 
16% (4) 
16% (4) 
24% (6) 
Education 
      8th Grade or Less 
      Some High School 
      Completed High School 
      1-3 Years College 
      4+ Years of College 
      Graduate School 
 
0% (0) 
5% (5) 
14% (14) 
40% (40) 
23% (23) 
18% (18) 
 
3.8% (1) 
0% (0) 
3.8% (1) 
46.2% (12) 
23.1% (6) 
23.1% (6) 
Knowledge of Genetics 
      Poor 
      Fair 
      Good 
      Very Good 
      Excellent 
 
19% (19) 
42% (42) 
27% (27) 
10% (10) 
2% (2) 
 
15.4% (4) 
26.9% (7) 
26.9% (7) 
19.2% (5) 
7.7% (2) 
* Comparison of gender distribution showed a significant difference (P=.038) 
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 variety of recruitment sites for the individuals who enrolled in the database (See Figure 5).  
While this correlation existed, it did not reach statistical significance (P=0.088) (See Table 13 in 
Appendix A).   
 
Enrolled in Database
68%
19%
3%
2% 1%4% 3%
Barbershop/Salon
Church
Community Service Organization
Health Fair
Retirement Center
Outside Contact
Other
Declined Database Participation
12%
8%
76%
4%
Barbershop/Salon
Church
Community Service Organization
Health Fair
Retirement Center
Outside Contact
Other
 
Figure 5 - Comparison of Recruitment Locations     
  
Finally, when each individual was asked to describe their experience, there was not a significant 
difference between those who enrolled in the database and those declined enrollment (See Tables 
13-16 in Appendix A).  However, it was noteworthy that of the total participants, 63.5% rated the 
experience as enjoyable, 71.4% rated the experience as informative, 3.2% rated the experience as  
“neutral”, and no one rated the experience as being uncomfortable.   
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Participants’ Opinions about Research   
  
The questionnaire addressed individuals’ opinions on different aspects of research.  Given that 
the aim of the database is to make individuals more aware of clinical research studies and 
potentially increase minority recruitment, it was hypothesized that there would be a significant 
difference in the attitudes and beliefs regarding research between those who enrolled in the 
database when compared to those who declined enrollment.   
 
Questions were asked on the post-questionnaire to determine whether participants were in favor 
of medical research and if they had a past history of participating in research.  All of the 
participants from both groups responded that they found medical research either very important 
or somewhat important.  The individuals in the database were slightly more likely to say that 
they found medical research very important, although the difference did not reach statistical 
significance (P=0.084) (See Table 17 in Appendix A).  In addition, the majority of individuals in 
both groups reported that they found research involving humans either very favorable or 
somewhat favorable and there was not a statistically significant difference between the 
individuals who elected to enroll and those who declined (See Table 18 in Appendix A).   Out of 
all participants (n=125), only 35 (28%) individuals had ever previously participated in a clinical 
trial.  There was no significant difference in the participation rate between individuals enrolled in 
the database and those who declined enrollment (See Table 19 in Appendix A).  However, there 
was a significant difference between the two groups when they were asked to report a past 
history of refusing to participate in a clinical study (P=0.044).  Individuals who declined 
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 enrollment in the database were more likely to have a history of refusing participation in a 
clinical study (See Table 20 in Appendix A).   
 
Questions within the post-questionnaire were asked to determine how various incentives (money, 
free medication, and free health care) impacted the likelihood that an individual would want to 
participate in research.  Each incentive was examined by comparing the proportion of individuals 
who responded that an incentive would make them more likely to participate to the number of 
individuals who responded otherwise.  More than half (55.2%) of total individuals who answered 
these questions (n=125) responded that $500 would make them more likely to participate in 
research.  In addition, the individuals enrolled in the database who responded (n=99) were 
significantly more likely to state that they would be more likely participate in clinical research 
when $500 (P=0.028) was offered as an incentive, in comparison to those individuals who did 
not enroll in the database (n=26) (See Table 3 and Table 21 in Appendix A).  Approximately 
53.6% of total individuals who responded (n=125) reported that free health care would increased 
the likelihood that they would participate in research.  It appears as though the incentive of free 
health care may also appeal more to the individuals in the database when compared to the 
individuals who declined enrollment, although the difference between the two groups did not 
reach statistical significance (P=0.072) (See Table 3 and Table 22 in Appendix A).  In regards to 
the incentive of free medication, 44% of total individuals reported that free medication would 
make them more likely to participate in research.  However, unlike the other incentives 
discussed, there was not a significant difference in individuals’ opinions on the effect of free 
medication between the two groups. (See Table 3 and Table 23 in Appendix A).   
Table 3 – Comparisons of Proportions for Effects of Incentives on Research Participation 
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 Incentive Enrolled in Database % (n) 
Declined Database 
% (n) 
$500*
     More likely to Participate 
     Other Response1
 
59.6% (59) 
40.4% (40) 
 
38.5% (10) 
61.5% (16) 
Free Health Care 
     More likely to Participate 
     Other Response1
 
57.6% (57) 
42.4% (42) 
 
38.5% (10) 
61.5% (16) 
Free Medication
     More likely to Participate 
     Other Response1
 
45.5% (45) 
54.5% (54) 
 
38.5% (10) 
61.5% (16) 
1-Other Responses: less likely to participate, no effect on participation, or uncertain of effect 
*Comparison of the effect of $500 showed a significant difference (P=0.028) 
 
Participants were asked on the post-questionnaire to describe the benefit that they felt different 
groups (e.g. scientists, community, family/friends, and themselves) received as a result of 
clinical research.    Virtually all of the participants felt that scientists benefit a great deal from 
clinical research.  Responses varied when it came to the benefit to the community, 
family/friends, or themselves; although the majority still felt that these groups benefited a great 
deal from clinical research.  In addition, there were no statistically significant differences in these 
opinions between the individuals who elected to enroll in the database and those individuals who 
declined enrollment (See Tables 24-27 in Appendix A). 
 
Individuals were also asked to consider a database such as the Minority Research Recruitment 
Database and to either provide expectations for such a database when they were interested in 
enrolling or to provide reasons why they would not be interested in enrolling.  Paradoxically, 
some individuals who enrolled in the database gave reasons for why they would not be interested 
in such a database and individuals who declined enrollment gave expectations for such a 
database.    Looking at responses from all participants, 103 of the 126 individuals provided 
expectations for such a database.  Of these individuals, 70% reported that they expected 
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 information on clinical studies for which they were eligible, 46.6% reported that they expected 
information on all clinical studies, 30.1% reported that they expected superior care by 
participating in studies, 19.4% reported that they expected incentives for participating in studies, 
and 7.8% gave additional expectations for a database such as the Minority Research Recruitment 
Database.  Such additional expectations included getting information pertaining to the health of 
them and their families and getting the results of the studies.  The remaining 23 individuals gave 
reasons why they would not be interested in such a database.  Of these individuals, 52.2% said 
that were not interested in any sort of database, 30.4% indicated that they did not want to 
disclose their contact information, 26.1% reported that they were not interested in research, 8.7% 
stated that they did not want to be part of anything that was related to their family health history, 
and 21.7% gave additional reasons as to why they would not be interested in a database such as 
the Minority Research Recruitment Database.  Additional reasons included time constraints, 
transportation constraints, and distrust of the research community.   
 
Participants’ Health Care  
 
 
On the pre-questionnaire, individuals gave information about their health care, including 
information about insurance coverage, their physician, and whether they communicated their 
concern about disease development with their physician.  In regards to insurance coverage, 
participants in the database were significantly less likely to have insurance coverage in 
comparison to individuals who declined enrollment (P=0.041) (See Table 28 in Appendix A).  
However, both groups were equally likely to respond that they were unable to see a physician 
due to cost over the past year (See Table 30 in Appendix A).  In regards to a primary care 
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 physician (PCP), the majority of individuals had one or more PCP and there was not a significant 
difference between the two groups (See Table 31 in Appendix A).     
 
  
Individuals were asked whether or not they were currently concerned about developing a chronic 
disease, how concerned they were, and whether or not they had talked to their physician about 
that concern.  Approximately 81.7% of total individuals were currently concerned and there was 
not a significant difference between those who enrolled in the database and those who declined 
enrollment (See Table 31 in Appendix A).  In addition, there was no difference between the two 
groups as to how they ranked their worry on a scale from 1-5 (1 being low and 5 being high).  
For the most part, individuals in both groups ranked their worry between a 1 and 3 (See Table 32 
in Appendix A).  When it came to communicating this concern to a physician,  who enrolled in 
the database were significantly more likely to have talked to their doctor about their worries in 
comparison to those individuals who declined enrollment (P=0.029) (See Figure 6 and Table 34 
in Appendix A).  This comparison excluded one individual who was uncertain whether or not she 
had expressed her concern with a physician.  
 
 
Participants who Enrolled into the 
Database
49%51%
Have Talked with a Doctor
Have Not Talked with a Doctor
Participants who Declined Enrollment 
into the Database
73%
27%
Have Talked with a Doctor
Have Not Talked with a Doctor
 
Figure 6 – History of Talking to a Physician about Concern for Developing a Condition 
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 Participant’s Personal Health Information 
 
In the pre-questionnaire, each individual was asked to rate their overall health.  In addition, 
during the family health history session, participants were asked to report any personal history of 
health problems.  Comparisons were made between the individuals who enrolled in the database 
and individuals who declined enrollment to detect any trends that existed between personal 
medical history and enrollment into the database.   
 
Each participant was asked on the pre-questionnaire to rate their health on a five-level scale, 
from poor to excellent.  There was a bell-curved distribution of responses.  The average worry 
rating for individuals who enrolled in the database was 2.6 in comparison to an average worry 
rating of 2.7 for individuals who declined enrollment in the database.  This difference was not 
statistically significant (See Table 34 in Appendix A).    
 
During the health history sessions, individuals were asked to describe any personal history of 
health problems.  The following conditions were then analyzed between the two comparison 
groups: heart disease, stroke, diabetes, colon cancer, prostate cancer, ovarian cancer, endometrial 
cancer, breast cancer, Alzheimer’s disease, hypertension, substance abuse, and mental illness.  
These are the same conditions for which each pedigree was analyzed.  The overall disease 
incidence was relatively low.  The most prevalent conditions included hypertension (n=43), 
diabetes (n=14), and prostate cancer (n=3).  There was not a significant difference in disease 
prevalence for any of the conditions between the individuals who enrolled in the database and 
those who declined enrollment (See Table 4 and Tables 35-46 in Appendix A).  In addition to 
looking at each disease independently, the diseases were combined together to see whether the 
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 presence of any condition was correlated with enrollment.  Once again, the presence of any 
condition was not correlated with the enrollment into the database (See Table 47 in Appendix A).  
Finally, the number of conditions that each individual reported was tabulated to discern any 
significant difference between the two groups.  A difference was not found between the number 
of conditions reported and whether or not the individual enrolled in the Minority Research 
Recruitment Database (See Table 48 in Appendix A).   
 
Table 4 – Prevalence of Common Diseases for our Study Participants (Probands) 
Condition 
Affected  
Enrolled  
% (n) 
Affected 
 Declined  
% (n) 
Affected  
Total 
% (n) 
Heart Disease 2% (2) 3.8% (1) 2.4% (3) 
Stroke 1% (1) 3.8% (1) 1.6% (2) 
Diabetes 9% (9) 19.2% (5) 11.1% (14) 
Colon Cancer 0% (0) 3.8% (1) 0.8%, (1) 
Prostate Cancer1 16.7% (3) 0% (0) 11.1% (3) 
Ovarian Cancer2 0% (0) 0% (0) 0% (0) 
Endometrial Cancer2 0% (0) 0% (0) 0% (0) 
Breast Cancer 2% (2) 3.8% (1) 2.4% (3) 
Alzheimer’s Disease 0% (0) 3.8% (1) 0.8%, (1) 
Hypertension 33% (33) 38.5% (10) 34.1% (43) 
Substance Abuse 3% (3) 3.8% (1) 3.2% (4) 
Mental Illness 7% (7) 3.8% (1) 6.3% (8) 
1- Prostate Cancer was evaluated for men only  
2 - Ovarian Cancer and Endometrial Cancer were evaluated for women only 
 
 
Participant’s Family History Information 
 
Within the pre-questionnaire, each individual was asked a few questions regarding family history 
information.  Following the family health history session, they were also queried on the post-
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 questionnaire to estimate their risk for a select group of chronic conditions as well as compare 
their risk to other individuals of the population who are of the same gender and age.  Also, 
information about each individual’s family was recorded on the pedigree and was later analyzed 
to place individuals in objective risk categories for a list of common diseases [23].  All of this 
family history information was then compared between the individuals who enrolled into the 
database and those who declined enrollment to ascertain any possible difference between the two 
groups. 
 
Analyzed responses from the pre-questionnaire revealed that 44.4% of the total participants 
(n=126) think that family history always contributes to disease risk and another 45.2% of 
individuals reported that family history sometimes contributes to disease risk.  Only 10.3% 
reported that family history never contributes to disease risk or were unsure of its contribution.  
There was not a significant difference in opinions between individuals enrolled in the database 
and those who declined enrollment (See Table 49 in Appendix A).  In addition, all individuals 
were asked whether or not they thought they had a family history of a chronic condition.  As a 
group, 78.6% of total individuals (n=126) responded that they thought they had a positive family 
history.  There was no significant difference in responses between the two groups (See Table 50 
in Appendix A). 
 
Within Section 1 of the post-questionnaire, each individual was asked to rate their risk (low, 
moderate, or high) for a list of common diseases: breast cancer, ovarian cancer (females only), 
prostate cancer (males only), colon cancer, lung cancer, heart disease, diabetes, Alzheimer’s 
disease, and hypertension.  Individuals in both groups tended to find themselves at low risk for 
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 breast cancer, ovarian cancer, colon cancer, lung cancer, and Alzheimer’s disease.  Individuals 
tended to have a more equal distribution of responses for prostate cancer, diabetes, and heart 
disease.  Also, the majority of total individuals perceived themselves to be high risk for 
hypertension.  When the group of individuals who enrolled in the database was compared to the 
groups of individuals who declined enrollment, no significant differences were found in risk 
perception for each individual disease (See Tables 51-59 in Appendix A).  In addition, the 
number of conditions for which each individual perceived themselves to be high-risk was 
tabulated.  The proportion of individuals who perceived themselves to be high risk for at least 
one condition was not significantly different between those who enrolled in the database and 
those who declined enrollment (See Table 60 in Appendix A).  The number of conditions that 
individuals perceived themselves to be high risk for did not differ significantly between the two 
groups (See Table 61 in Appendix A).   
 
On the post-questionnaire, each individual was asked to compare their risk for a particular 
chronic disease to other individuals in the general population of the same gender and of the same 
age.  They rated their risk as either much lower, somewhat lower, the same, somewhat higher, 
much higher, or uncertain.  The list of conditions was the same list of conditions for which they 
had to rate their own risk.  For the majority of conditions, individuals rated their risk as much 
lower or somewhat lower than the general population.  The exceptions were hypertension, 
diabetes, heart disease, and prostate cancer.  For these conditions, there was a wider distribution 
of responses.  As with the questions on risk perception, there was not a significant difference in 
risk comparison between the individuals who enrolled in the database and those who declined 
enrollment (See Tables 62-70 in Appendix A).    
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Finally, each pedigree’s family history information was analyzed to place individuals in 
objective risk categories for a variety of chronic conditions using Scheuner’s Guidelines for Risk 
Stratification [23].  Then, for each condition, the proportion of individuals at each risk level was 
compared between the individuals in the database and those not in the database.  None of the 
conditions had statistically significant differences in risk distributions between the two 
comparison groups (See Table 5 and Tables 71-82 in Appendix A). 
 
For each individual’s family health history, all of the conditions were analyzed together to see if 
they were considered to be high-risk for at least one condition.  Of total individuals (n=126), 
73% were high risk for at least one common disease and there was not a significant difference 
between the individuals who elected to be entered in the database and those who declined (See 
Table 83 in Appendix A).   Also, the number of conditions for which each individual was 
considered to be high-risk was tabulated.  The majority of individuals were at high risk for 0, 1, 
or 2 conditions.  There was not a statistically significant difference in the comparison of the 
number of high-risk conditions between the two groups (See Table 85 in Appendix A).   
 
Lastly, the tendency of individuals to under-estimate, over-estimate, or accurately estimate their 
risk was analyzed.  This was done by comparing actual risk (using Scheuner’s Risk Stratification 
Guidelines [23] ) to perceived risk (based upon participant’s responses on the post-
questionnaires).  The number of conditions where individuals over-estimated their risk ranged 
from 0-6, although the majority of individuals (84.9%) only over-estimated their risk on 0-3 
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 Table 5- Comparison of Proportion of Individuals' At Risk for Common Disease based upon Family History 
using Sheuner's Risk Stratification 
Condition Enrolled (n=100) % (n) 
Declined (n=26)  
% (n) 
Total  (n=126) 
% (n) 
Heart Disease 
       Average Risk 
       Moderate Risk 
       High Risk 
 
40% (40) 
20% (20) 
40% (40) 
 
42.3% (11) 
7.7% (2) 
50% (13) 
 
40.5% (51) 
17.5% (22) 
42% (53) 
Stroke 
       Average Risk 
       Moderate Risk 
       High Risk 
 
75% (75) 
19% (19) 
6% (6) 
 
84.6% (22) 
7.7% (2) 
7.7% (2) 
 
77% (97) 
16.7% (21) 
6.3% (8) 
Diabetes 
       Average Risk 
       Moderate Risk 
       High Risk 
 
47% (47) 
21% (21) 
32% (32) 
 
61.5% (16) 
15.4% (4) 
23.1% (6) 
 
50% (63) 
19.8% (25) 
30.2% (38) 
Colon Cancer 
       Average Risk 
       Moderate Risk 
       High Risk 
 
95% (95) 
4% (4) 
1% (1) 
 
88.5% (23) 
11.5% (3) 
0% (0) 
 
93.7% (118) 
5.6% (7) 
0.8% (1) 
Prostate Cancer1 
       Average Risk 
       Moderate Risk 
       High Risk 
 
83.3% (15) 
16.7% (3) 
0% (0) 
 
100% (9) 
0% (0) 
0% (0) 
 
88.9%(24) 
11.1% (3) 
0% (0) 
Ovarian Cancer2 
       Average Risk 
       Moderate Risk 
       High Risk 
 
96.3% (79) 
0% (0) 
3.7% (3) 
 
94.1% (16) 
5.9% (1) 
0% (0) 
 
96% (95) 
1% (1) 
3% (3) 
Endometrial Cancer2 
       Average Risk 
       Moderate Risk 
       High Risk 
 
98.8% (81) 
0% (0) 
1.2% (1) 
 
94.1% (16) 
0% (0) 
5.9% (1) 
 
98% (97) 
0% (0) 
2% (2) 
Breast Cancer 
       Average Risk 
       Moderate Risk 
       High Risk 
 
87% (87) 
7% (7) 
6% (6) 
 
88.5% (23) 
3.8% (1) 
7.7% (2) 
 
87.3% (110) 
6.3% (8) 
6.3% (8) 
Alzheimer’s Disease 
       Average Risk 
       Moderate Risk 
       High Risk 
 
93% (93) 
5% (5) 
2% (2) 
 
96.2% (25) 
0% (0) 
3.8% (1) 
 
93.7% (118) 
4% (5) 
2.4% (3) 
Hypertension 
       Average Risk 
       Moderate Risk 
       High Risk 
 
33% (33) 
16% (16) 
51% (51) 
 
30.8% (8) 
30.8% (8) 
38.5% (10) 
 
32.5% (41) 
19% (24) 
48.4% (61) 
Substance Abuse 
       0-1 Relatives  
       2+ Relatives 
 
78% (78) 
22% (22) 
 
76.9% (20) 
23.1% (6) 
 
77.8% (98) 
22.2% (28) 
Mental Illness 
       0-1 Relatives 
       2+ Relatives 
 
93% (93) 
7% (7) 
 
96.2% (25) 
3.8% (1) 
 
93.7% (118) 
6.3% (8) 
1- Prostate Cancer was evaluated for men only  
2 – Ovarian Cancer and Endometrial Cancer were evaluated for women only 
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 conditions.  There was not a significant difference in the number of over-estimated conditions 
between the individuals who chose to enroll in the database and those who declined enrollment 
(See Table 85 in Appendix A). The number of conditions that individuals under-estimated their 
risk ranged from 0-5, although the majority of individuals (96%) only under-estimated their risk 
on 0-2 conditions.  Once again, there was not a significant difference between the comparison 
groups (See Table 86 in Appendix A).  Finally, the number of conditions that individuals 
accurately estimate their risk ranged from 0-7, although the majority of individuals (80.2%) were 
accurate in 2-6 conditions.  There was not a significant difference in accurate risk estimation 
between the individuals who enrolled in the database and those who declined enrollment (See 
Table 87 in Appendix A).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
53 
 DISCUSSION 
 
 
Overall, it appears as though the use of family health histories for dissemination of information 
on clinical research was effective for this project.  The majority (79.4%) of individuals (n=126) 
who completed their family health history elected to enroll into the Minority Research 
Recruitment Database.  It is possible that as individuals continue to enroll in the database, more 
studies will be identified for which they may be eligible.  To date, clinical trial information has 
been sent to eight individuals: studies on breast cancer, prostate cancer, and Crone’s Disease. 
Additional research can be completed to determine the effectiveness of the database in increasing 
minority recruitment once information has been sent to a greater number of participants.  
 
In addition, in less than one year, 175 individuals were able to complete family health histories.  
Since the completion of this study, a variety of other groups have shown interest in participating 
in this initiative.  This study provides evidence that the Family Health History Initiative appeals 
to the African American population of Pittsburgh and that a health screening service is being 
provided to a group of individuals who have been shown to be underserved and suffer from 
health disparities.       
 
Demographics of the Study Population 
 
Demographic characteristics were compared between the individuals who enrolled in the 
database and those who declined enrollment.  With the exception of gender, demographics did 
not differ between the two groups.  For this project, women were more likely to complete their 
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 family health histories and complete the questionnaires in comparison to men.   This may be a 
consequence of the nature of this study as it deals with health information and the family.  
Women play a key role in health care seeking behavior, for both themselves and their family 
members.  In general, they are more experienced and knowledgeable health care consumers in 
comparison to men. [48] Another possible explanation for the gender difference is that women 
simply outnumbered men in many of the locations of recruitment.  Therefore, future recruitment 
sites should be focused on locations where there is a greater proportion of men.  Additionally, it 
may be possible that the differences in gender participation are a reflection of less interest by the 
male population.  Perhaps men are not as aware of health issues within their family and 
therefore, were not as interested in participating.  
 
 At a recent gathering of individuals who completed their family health histories, we asked 
African American men to give reasons as to why they felt there was such a low participation rate 
by African American men.  Many men suggested that it was an issue of male pride.  One man 
stated that when most men get sick, they continue their daily lives and do not want to talk about 
it.  Another man alluded to the fact that men want to be seen as strong individuals and so they do 
not want to discuss issues that may make them appear otherwise.  Future research should listen 
to what these and other men have to say about barriers for family health history participation and 
attempt to provide a local public health message that encourages men to talk about health and 
disease and emphasize why they, as men, would benefit from talking about their health and the 
health of their families.    In addition, to determine the appeal of this project to the male 
population, a study could analyze the total number of men and women at each recruitment site 
and then determine the number of each gender who refuse participation, who show initial interest 
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 but do not complete the family health history process, who actually complete their family health 
history, and who actually enroll in the Minority Research Recruitment Database.  
 
Recruitment Variables 
 
A few variables from each individual’s family health history session were analyzed to look for 
any uncontrolled external factors that may have influenced an individual’s decision to enroll in 
the database.  It was determined that the location of recruitment and the student performing the 
health history session did not appear to influence an individual’s decision towards enrollment.  In 
addition, when individuals were asked to describe their family health history session, virtually all 
individuals described it as either informative, enjoyable, or both.  No one described it as 
uncomfortable and only a few individuals had a neutral opinion about this experience.  It is 
encouraging to learn that no one had a bad experience with the family health history sessions.  It 
is possible to consider that the overall high enrollment rate into the database may reflect the high 
percentage of individuals who had an enjoyable and/or informative experience. 
 
Participants’ Opinions about Research 
  
Participants responded to various questions about their attitudes and beliefs regarding research.  
Individuals who enrolled in the database were significantly more likely to respond that monetary 
incentives would increase their likelihood of research participation.  This finding is consistent 
with other research studies.  Cunny and Miller (1994), for example, found that financial 
compensation was the primary motivation for participation in a clinical drug study. [49, 50] 
Similarly, in a study of 440 participants, 53.3% of individuals indicated that they participated as 
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 a result of financial motives. [51] This suggests that monetary incentives may enhance research 
recruitment in general, and therefore, it is possible that the hope of receiving monetary rewards 
has influenced individuals to enroll in the database.  This may have ethical implications, 
however.  While some ethicists argue that some level of inducement is necessary to prompt 
recruitment, other ethicists are concerned that monetary incentives lead individuals to expose 
themselves to risk in a study for which they would not participate in otherwise. [50] Of similar 
ethical concern is the fact that individuals who enrolled in the database appeared to be more 
likely to report that free health care would increase the likelihood for participation in research.  
Cassileth, et. al. (1982) showed that 52% of individuals reported that their main reason for 
participation was the opportunity for best medical care. [49] Given that 13% of individuals who 
enrolled in the database do not have health insurance, it is of concern that individuals may use 
the database as a substitution for health care.  To address this issue, the Center for Minority 
Health is continually locating resources for low-cost health insurance.  Finally, it was interesting 
to see that individuals were less likely to report that free medication would increase the 
likelihood to participate in clinical trials, in comparison to the other two incentives.  Medications 
are potentially hazardous to one’s health, unlike free health care or monetary incentives.  This 
potential risk may be why individuals are less likely to be attracted to such an incentive.  Future 
research could examine the attitudes of participants towards various incentives and could address 
the ethical dilemmas that incentives pose in clinical trials.   
 
Despite the fact that individuals in the database are more likely to be participate in research when 
given incentives, it is important to emphasize that a significant percentage (40-42%) of 
individuals in the database report that monetary incentives and free health care do not make them 
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 more likely to participate in research.  Many of these individuals may have an altruistic motive 
behind their decision to enroll in the database.  Future studies may wish to explore participants’ 
motives for enrolling in the Minority Research Recruitment Database.   
 
Another finding regarding attitudes towards research was the similar proportion of previous 
participation in a clinical trail among individuals who enrolled and those who declined 
enrollment.  In contrast, a greater proportion of individuals who declined participation in the 
database have a past history of declining participation in clinical research.  These two findings 
suggest that some individuals in the declined group may have participated in research at one 
point but have since decided to decline participation.  In the future, it would be interesting to 
have individuals describe their research experiences and try to uncover reasons for declining 
participation.  Corbie-Smith et. al conducted a study in which they developed an index of distrust 
that could be used to evaluate individuals’ levels of distrust of the research community.  This 
distrust index is based upon seven questions from a questionnaire about attitudes and beliefs 
regarding research [18].  Some of the questions used in the present study were taken from the 
questionnaire used in Corbie-Smith’s study; however none of the questions came from the index 
of distrust.  It would be interesting to use this index of distrust with future participants and 
measure the correlation between distrust and declining enrollment in the database.   
 
Individuals were also asked within the questionnaire to consider a database such as the Minority 
Research Recruitment Database and to either give expectations for such a database or to give 
reasons for not having interest.  As stated previously, this is not where individuals actually 
enrolled in the database, rather a theoretical database that serves the same purpose as the 
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 Minority Research Recruitment Database.  These questions were created to directly assess 
reasons for enrolling in the database and reasons for declining enrollment.  Interestingly enough, 
some individuals who actually enrolled in the database by signing the informed consent form 
indicated on the survey that they were not interested and gave reasons for not having interest.  
Similarly, several individuals who declined enrollment into the database during the consent 
process indicated on the survey that they would be interested in a database like the Minority 
Research Recruitment Database and gave their expectations.  This could possibly suggest that 
people did not completely understand these particular questions, they misunderstood what they 
were doing when they signed the informed consent form that enrolled them into the database, or 
that they liked the idea of the database in theory but were not interested when it came time to 
actually enroll.  Never the less, it was interesting to see the expectations given for the database. 
Most people indicated that they expected to receive information on some or all clinical trials.  
This suggests that these individuals understood the purpose of the database.  In addition, 
individuals indicated that they expected incentives (including superior healthcare), which 
reinforces the aforementioned findings regarding how incentives may have influenced 
individuals’ decisions to enroll.  Finally, it was interesting to see the reasons for declining the 
database.  Surprisingly, the majority of people did not respond that they declined due to lack of 
interest with research.  Rather, most people were just not interested in enrolling in a database or 
disclosing their contact information.   This suggests that some participants who declined 
enrollment may still be interested in participating in research but are not interested in the 
Minority Research Recruitment Database. Future studies may involve conducting focus groups 
with the individuals who declined enrollment in the database in hopes of further clarifying their 
attitudes towards research.  If they appear to have any interest in participating in research, it 
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 would be beneficial to have these individuals help identify other ideas for the dissemination of 
information on clinical research trials.   
 
Participants’ Health Care 
 
 
Results revealed that individuals without health insurance were more likely to enroll in the 
database.  This may be help clarify why some individuals, both those who enrolled in the 
database and those who declined enrollment, stated that incentives such as free health care and 
free medication would make them more likely to participate in research.  As mentioned  
previously, it is of ethical concern that individuals may participate in research as a means of 
obtaining health care. [49] There are other programs available in the Pittsburgh area, such as 
Primary Care Health Services, Inc, that are superior choices for individuals seeking no-cost or 
low-cost health care.  It is important to make individuals aware of these other health care options 
so that clinical studies are not used as a substitute for necessary medical care.  
 
Individuals who enrolled in the database were more likely to have spoken with a physician in the 
past year about their concern for developing a disease.  It is possible that these individuals have a 
more trusting relationship with their physician.  The literature suggests that trust and distrust of 
physicians and other health care providers are linked to trust and distrust of researchers as well 
[18].  Therefore, it could be hypothesized that individuals who have talked with their physicians 
about these concerns have not only more trust in their physicians than the individuals who 
declined, but that they are more trusting of researchers.  The possibility that those individuals 
who decline enrollment have a lack of trust in researches is plausible based on other studies that 
have documented the lack of trust as being one of the largest barriers to minority participation in 
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 research [11, 18].  Once again, these results require additional study to further evaluate the issues 
of trust and distrust in potential participants.  For example, individuals’ levels of trust could be 
objectively analyzed using the aforementioned distrust index scale.   
 
 
Participants’ Personal Health Status 
 
Participant’s personal health status (i.e. affected with specific conditions) was compared between 
individuals who enrolled in the database and those who declined enrollment.  There was no 
correlation between being affected with a condition and enrolling in the database.  In addition, 
the number of conditions that an individual had was not correlated with enrollment in the 
database.  It is possible that the limited sample size and the relatively small number of 
individuals who are currently affected by disease may be a limitation in this analysis.  Perhaps as 
the study population grows, we will be able to say more definitively whether or not personal 
health influences individuals’ interest in research and the database.   
 
Participants Family Health Information 
 
  
Each individual’s family health history was examined to determine if factors within one’s family 
history influenced their likelihood to enroll in the database.  We did not find that being at risk for 
a particular condition based upon family history information was linked to enrollment into the 
database.  In addition, having a family history of substance abuse or mental health did not effect 
enrollment in the study.    However, it is possible that individuals were reluctant to report family 
history of these conditions.  Perhaps, individuals are not reporting a family history of substance 
abuse or mental health and yet it is deterring their choice to enroll in the database.   
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It is possible that some individuals were unfamiliar with their risk or inaccurately estimated their 
risk for developing certain diseases based on family history and for this reason, risk perception 
and its influence on enrollment was examined.  It was hypothesized that individuals who 
considered their risk to be high would be more likely to enroll.  There was no correlation 
between perceived risk and inclination to enroll.  In addition, we determined individuals’ 
tendency to underestimate or overestimate their risk by comparing their actual risk to their 
perceived risk.  Additionally, individuals who overestimated their risk were not more likely to 
enroll.  In fact, it appears that no aspect of family history was correlated with the decision to 
enroll in the Minority Research Recruitment Database.  Once again, however, this may be a 
result of a limited sample size and the fact that some conditions were relatively uncommon in our 
study population, making it difficult to find significant differences.   
   
Limitations of this Study 
 
It was quite an accomplishment to recruit 126 individuals in less than one year’s time.  In 
addition, it was very pleasing to see that of these 126 individuals, 100 enrolled in the database.  
This enrollment rate was virtually 80%, far exceeding the expectations of the project.  However, 
as a result of the majority of participants enrolling in the study, the sample size of individuals 
who declined was relatively small.   This small sample size was especially limiting when a 
question had a large variety of possible responses.  The larger the number of possible responses 
for a question, the smaller the number of individuals per response group and the more difficult it 
is to find significance when comparing groups.  Therefore, in order to make the study more 
statistically robust, it is necessary to continue recruitment.   
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In addition to a relatively limited sample size, the number of men who participated was quite 
small.  This makes it more difficult to generalize many of these results to both men and women.  
Future studies should focus on going to recruitment sites where more men are present.   
 
Another limitation to this study was the total number of statistical tests conducted on a large set 
of data.  Since the use of family history information to enroll individuals into recruitment 
database is virtually unprecedented, it was difficult to make specific hypotheses.  Rather, we 
made a large number of comparisons to see what factors warrant further, more specific 
investigation.  Consequently, it is difficult to assess the robustness of the significance identified 
with the current results.  It is possible that through multiple testing, some of the significant 
differences were found just by chance.   
 
This was an exploratory study in which each variable was analyzed separately, without looking 
at any multivariate analyses to see variable interactions.  It is possible that some variables are 
correlated with one another and the interaction between variables may be a confounding factor.  
Further analysis of any one or two single significant variables may help to clarify the significant 
findings of the others.   
 
Another limitation to this research involved the study population itself.  The individuals who 
answered the questionnaires were not chosen at random, but rather were a self-selected group of 
individuals who were highly motivated to take the time to complete their family health histories. 
Therefore, it is difficult to generalize these results to the entire African American community in 
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 Pittsburgh.  For example, these individuals might already have enough trust in the research 
community to participate in this study.  Therefore, their views of research may differ 
significantly from the general African American population.   
 
Additional Indications for Future Studies 
 
Because this initiative is relatively unstudied and warrants further exploration, there are 
additional studies that might be conducted in the future, some of which have already been 
mentioned.  To follow are just a few additional ideas for future research. 
 
Increasing the sample size and repeating the analysis would further enhance this study.  This 
would involve increasing not only the total sample size, but also the representation of men.  As 
the overall sample size increased, the number of declined individuals would most likely increase 
as well, thus making for a more significant overall comparison.  In addition, some of the 
questions with the wider range of responses may result in significant results once the study 
population has reached an appropriate size.   
 
Multivariate analyses should be run on the dataset.  A logistic regression analysis would allow 
the significant variables to be compared to determine how the variables are interacting and to 
identify whether any one or two variables are driving the other variables towards significance.  
By performing a multivariate analysis, results could be adjusted appropriately and the issues of 
multiple testing or multiple variable interactions could be addressed.   
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 Creation of a questionnaire that examines attitudes and beliefs about research is suggested.  This 
instrument could compare individuals who complete their family health history and individuals 
who do not have interest in completing their family health history.  This would assist with 
interpretation of the research beliefs of the study population and help further explain the 
differences between those who enroll in the database and those who decline.  It would also be 
interesting to compare demographic information between those individuals who do not show 
interest in the family health histories, those who sign up but never complete the process, those 
who sign up and complete their family health history, and those who sign up, complete their 
family health history, and enroll in the database.  
 
Recruitment of non-African-American participants could determine whether any of the 
significant findings are unique to the African American population.  Additional research could 
then explore possible reasons for any differences that exist in the African American population.  
Similarly, by conducting this study at other sites, it would be possible to assess whether the 
opinions of African Americans in Pittsburgh represented the opinions of African Americans 
elsewhere.   
 
Additional analysis could be performed from the data collected on the one-month follow-up.  It 
could be determined how many individuals actually shared the information with their physicians 
or families.  It would be ideal to conduct further research on these participants to examine if the 
family health history lead to behavior modification towards healthier lifestyles and disease 
prevention.   
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 Finally, once the Center for Minority Health begins to send more information on clinical 
research trials, it may be possible to contact participants and analyze which individuals actually 
contacted the study coordinators and actually enrolled in clinical research studies.  This would 
ultimately determine the impact and effectiveness of family health histories in increasing 
minority recruitment in clinical research trials.   
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 EPILOGUE 
 
 When coming to the Center for Minority Health (CMH) almost two years ago, I did not 
realize what lay ahead.  I was coming from a white, middleclass, suburban town, having never 
experienced life within the African American community.  My first experience with CMH was in 
a black barbershop in which I was supposed to talk to individuals about the importance of 
knowing family history information.  To be honest, I was very intimidated.  After all, I was not 
used to being the “minority” within a setting.  I felt that I was very out of place and that everyone 
surrounding me was thinking the exact same thing.  Following this event, I was questioning my 
decision to work for CMH. 
 
 I decided to just give myself time to adjust to a new environment.  As I began to spend 
more time in the black community, being the “minority” became less of an issue.  It is almost as 
if racial lines began to disappear.  I felt that as I became more comfortable in my setting, 
participants began to feel more comfortable with me.  For example, there was one particular 
black church that we often frequented to complete family health histories.  After a couple of 
months, I had past participants coming up to me before and after services, giving updates on their 
lives as if we were old friends.  I felt as though I had become part of their community. 
 
 When I am asked what I learned from this research, I do not recall my analysis of 
participants in the database.  Rather, I speak of what I have learned while being in the black 
community.  I have learned to be a more culturally-sensitive, culturally-competent health 
professional.  In my opinion, this is not something easily learned, yet it is something that is 
extremely important in becoming a good genetic counselor.   
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 Demographics of the Study Population 
 
 
Table 5- Gender Distribution 
 Males Females 
Participants Enrolled in the Database 18 82 
Participants who Declined Enrollment 9 17 
Total 27 99 
P=0.038 (Binomial Test of Proportions) 
Table 6- Race/Ethnicity Distribution  
 
 
African American  
Only 
African American 
 and Other 
Participants Enrolled in the Database 91 9 
Participants who Declined Enrollment 24 2 
Total 115 11 
P=1.000 (Binomial Test of Proportions) 
Table 7- Age Distribution 
 18-35 36-50 51-65 66+ 
Participants Enrolled in the Database 13 41 33 13 
Participants who Declined Enrollment  4 10 9 3 
Total 17 51 42 16 
P=0.982 (Fisher’s Exact Test) 
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 Table 8- Income Level Distribution 
 <$10,000 $10,001- $20,000 
$20,001- 
$35,000 
$35,001- 
$50,000 
$50,001- 
$75,000 $75,001+ 
Participants Enrolled in the 
Database 
 
4 
 
17 
 
25 
 
18 
 
13 
 
20 
Participants who Declined 
Enrollment 
 
2 
 
4 
 
 
5 
 
4 
 
4 
 
6 
Total 6 21 30 22 17 26 
P=0.932 (Fisher’s Exact Test) 
 
 
Table 9- Education Level Distribution 
 Grade 8 or Less 
Some 
High 
School 
Completed 
High 
School 
1-3 years 
College/ 
Technical 
School 
4+ years 
of College 
Graduate  
School 
Participants Enrolled 
in the Database 0 5 14 40 23 18 
Participants who 
Declined Enrollment 1 0 1 12 6 6 
Total 1 5 15 52 29 24 
P=0.282 (Fisher’s Exact Test)  
 
 
Table 10- Ranking of Personal Knowledge of Genetics 
 Poor Fair Good Very Good Excellent 
Participants Enrolled in the 
Database 19 42 27 10 2 
Participants who Declined 
Enrollment 4 7 7 5 2 
Total 23 49 34 15 4 
P=0.249 (Fisher’s Exact Test) 
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 Participants’ Family Health History Session 
 
Table 11- Counseling Student Performing the Family Health History Session 
 Kristen Vogel Vinaya Murthy Beth Dudley 
Participants Enrolled in 
the Database 36 49 15 
Participants who 
Declined Enrollment 13 10 3 
Total 49 59 18 
P= 0.448 (Fisher’s Exact Test) 
 
 
Table 12- Location of Recruitment 
 Barbershop/Salon Church 
Community 
Service 
Org. 
Health 
Fair 
Retirement 
Center 
Outside 
Contact Other 
Participants Enrolled in 
the Database 3 68 3 19 4 2 1 
Participants who 
Declined Enrollment 0 20 0 1 3 0 2 
Total 3 88 3 20 7 2 3 
P=0.088 (Fisher’s Exact Test) 
 
 
Table 13- Had an Enjoyable Family Health History Session 
 Yes No 
Participants Enrolled in the Database 63 37 
Participants who Declined Enrollment 17 9 
Total 80 46 
P=1.000 (Binomial Test of Proportions) 
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 Table 14- Had an Informative Family Health History Session 
 Yes No 
Participants Enrolled in the Database 72 28 
Participants who Declined Enrollment 18 8 
Total 90 36 
P=0.827 (Binomial Test of Proportions) 
 
 
Table 15- Had an Uncomfortable Family Health History Session 
 Yes No 
Participants Enrolled in the Database 0 100 
Participants who Declined Enrollment 0 26 
Total 0 126 
P=1.000 (Binomial Test of Proportions) 
 
 
Table 16- Had No Opinion about the Family Health History Session 
 Yes No 
Participants Enrolled in the Database 3 97 
Participants who Declined Enrollment 1 25 
Total 4 122 
P=0.547 (Binomial Test of Proportions) 
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 Participant’s Opinions about Research 
 
Table 17 - General Opinion on Importance of Medical Research  
 Very Important Somewhat Important 
Participants Enrolled in the Database 95 4 
Participants who Declined Enrollment 23 3 
Total 118 7 
P=0.084 (Binomial Test of Proportions) 
 
Table 18- General Opinion about Clinical Research Involving Humans 
 Very Favorable 
Somewhat 
Favorable Neutral 
Somewhat 
Unfavorable 
Very 
Unfavorable Uncertain
Participants 
Enrolled in the 
Database 
53 38 3 2 0 2 
Participants 
who Declined 
Enrollment 
12 12 0 2 0 0 
Total 65 50 3 4 0 2 
P=0.169 (Fisher’s Exact Test) 
 
Table 19- Previous History of Participating in a Clinical Trial 
 Have Participated in Clinical Trials 
Have Never Participated in 
a Clinical Trial 
Participants Enrolled in the Database 28 71 
Participants who Declined Enrollment 7 19 
Total 35 90 
P=1.000 (Binomial Test of Proportions) 
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 Table 20- Past History of Declining Enrollment in a Clinical Study 
 History of Declining Enrollment 
Never Declined 
Enrollment Uncertain 
Participants Enrolled in 
the Database 29 69 1 
Participants who 
Declined Enrollment 11 13 2 
Total 40 82 3 
P=0.044 (Fisher’s Exact Test) 
 
Table 21- Effect of $500 on Clinical Research Participation 
 Less likely to Participate 
More likely to 
Participate 
No Effect on 
Participation 
Uncertain of 
Effect 
Participants Enrolled in the 
Database 7 59 20 13 
Participants who Declined 
Enrollment  1 10 12 3 
Total 8 69 32 16 
P=0.066 (Fisher’s Exact Test) vs. 0.028 (Binomial Test) * 
*Two groups: Those more likely to participate vs. all other responses 
 
 
Table 22- Effect of Free Medical Care on Clinical Trial Participation 
 Less likely to Participate 
More likely to 
Participate 
No Effect on 
Participation 
Uncertain of 
Effect 
Participants Enrolled in the 
Database 6 57 32 4 
Participants who Declined 
Enrollment  4 10 10 2 
Total 10 67 42 6 
P=0.151 (Fisher’s Exact Test), P=0.072 (Binomial Test) * 
*Two groups: Those more likely to participate vs. all other responses 
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 Table 23- Effect of Free Medication on Clinical Trial Participation 
 Less likely to Participate 
More likely to 
Participate 
No Effect on 
Participation 
Uncertain of 
Effect 
Participants Enrolled in the 
Database 10 45 34 10 
Participants who Declined 
Enrollment  2 10 9 5 
Total 12 55 43 15 
P=0.623 (Fisher’s Exact Test) vs. P=0.557 (Binomial test)* 
*Two groups: Those more likely to participate vs. all other responses 
 
Table 24- Opinion on the Degree to which Scientists Benefit from Clinical Research 
 Great 
Deal 
Moderate 
Amount 
Only a 
Little 
Not at All Depends 
Participants Enrolled in the 
Database 80 13 1 0 5 
Participants who Declined 
Enrollment 23 3 0 0 0 
Total 103 16 1 0 5 
P=0.777 (Fisher’s Exact Test) 
 
Table 25- Opinion on the Degree to which the Community Benefits from Clinical Research 
 Great 
Deal 
Moderate 
Amount 
Only a 
Little 
Not at All Depends 
Participants Enrolled in the 
Database 52 29 11 0 8 
Participants who Declined 
Enrollment 14 6 1 0 5 
Total 66 35 12 0 13 
P=0.31 (Fisher’s Exact Test) 
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 Table 26- Opinion on the Degree to which Family/Friends Benefit from Clinical Research 
 Great 
Deal 
Moderate 
Amount 
Only a 
Little 
Not at All Depends 
Participants Enrolled in the 
Database 56 24 14 1 5 
Participants who Declined 
Enrollment 13 7 1 0 5 
Total 69 31 15 1 10 
P=0.123 (Fisher’s Exact Test) 
 
 
Table 27- Opinion on the Degree of Personal Benefit from Clinical Research 
 Great 
Deal 
Moderate 
Amount 
Only a 
Little 
Not at All Depends 
Participants Enrolled in the 
Database 67 20 6 1 6 
Participants who Declined 
Enrollment 15 7 0 0 0 
Total 82 27 6 1 6 
P=0.316 (Fisher’s Exact Test) 
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 Participant’s Health Care 
 
Table 28- Insurance Coverage  
 
Insurance Coverage No Insurance Coverage 
Participants Enrolled in the 
Database 87 13 
Participants who Declined 
Enrollment 26 0 
Total 103 13 
P=0.041  (Binomial Test of Proportions) 
 
 
Table 29- Presence of Primary Care Physician (PCP)  
 No PCP One PCP More than One PCP 
Participants Enrolled in 
the Database 11 59 30 
Participants who 
Declined Enrollment 1 17 8 
Total 12 76 38 
P=0.637 (Fisher’s Exact Test) 
 
 
Table 30- Unable to See a Physician Due to Cost in the Past Year 
 Unable due to Cost Cost did not Interfere Uncertain 
Participants Enrolled in 
the Database 10 89 1 
Participants who 
Declined Enrollment 2 24 0 
Total 12 113 1 
P=1.000 (Fisher’s Exact Test) 
77 
 Table 31- Current Concern about Developing a Chronic Disease 
 Worried Not Worried 
Participants Enrolled in the 
Database 82 18 
Participants who Declined 
Enrollment 21 5 
Total 103 23 
P=0.801 (Binomial Test of Proportions) 
 
 
Table 32- Level of Worry for Developing a Chronic Condition (Scale of 1-5) 
 Worry : 1 Worry : 2 Worry : 3 Worry : 4 Worry : 5 
Participants Enrolled 
in the Database 
15 31 38 5 8 
Participants who 
Declined Enrollment 
5 5 12 2 2 
Total 20 36 50 7 10 
P=0.738 (Fisher’s Exact Test) 
 
Table 33- History of Talking to a Physician about Concern for Developing a Condition 
 Have Talked to a Physician 
Have not Talked to a 
Physician Uncertain 
Participants Enrolled in 
the Database 49 50 1 
Participants who 
Declined Enrollment 7 19 0 
Total 
56 69 1 
P=0.092 (Fisher’s Exact Test)* and P=0.018 (Binomial Test of Proportions)** 
*Includes uncertain individual  **Excludes uncertain individual 
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 Participant’s Personal Health Information 
 
Table 34- General Health 
 Poor Fair Good Very Good Excellent 
Participants Enrolled in the 
Database 2 21 54 19 4 
Participants who Declined 
Enrollment 0 4 11 9 2 
Total 2 25 65 28 6 
P=0.350 (Fisher’s Exact Test) 
 
 
Table 35- Personal History of Heart Disease 
 Positive History Negative History 
Participants Enrolled in the Database 2 98 
Participants who Declined Enrollment 1 25 
Total 3 123 
P=0.409 (Binomial Test of Proportions) 
 
Table 36- Personal History of Stroke  
 Positive History Negative History 
Participants Enrolled in the Database 1 99 
Participants who Declined Enrollment 1 25 
Total 2 124 
P=0.230 (Binomial Test of Proportions) 
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 Table 37- Personal History of Diabetes 
 Positive History Negative History 
Participants Enrolled in the Database 9 91 
Participants who Declined Enrollment 5 21 
Total 14 112 
P=0.079 (Binomial Test of Proportions) 
 
 
Table 38- Personal History of Colon Cancer 
 Positive History Negative History 
Participants Enrolled in the Database 0 100 
Participants who Declined Enrollment 1 25 
Total 1 125 
P=0.206 (Binomial Test of Proportions) 
 
 
Table 39- Personal History of Prostate Cancer  
 Positive History Negative History 
Participants Enrolled in the Database 3 15 
Participants who Declined Enrollment 0 9 
Total 3 24 
P=0.372 (Binomial Test of Proportions) 
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 Table 40-Personal History of Breast Cancer 
 Positive History Negative History 
Participants Enrolled in the Database 2 98 
Participants who Declined Enrollment 1 25 
Total 3 113 
P=0.230 (Binomial Test of Proportions) 
 
 
Table 41- Personal History of Ovarian Cancer 
 Positive History Negative History 
Participants Enrolled in the Database 0 82 
Participants who Declined Enrollment 0 17 
Total 0 99 
P=1.00 (Binomial Test of Proportions) 
 
 
Table 42- Personal History of Endometrial Cancer 
 Positive History Negative History 
Participants Enrolled in the Database 0 82 
Participants who Declined Enrollment 0 17 
Total 0 99 
P=1.00 (Binomial Test of Proportions) 
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 Table 43- Personal History of Alzheimer’s Disease 
 Positive History Negative History 
Participants Enrolled in the Database 0 100 
Participants who Declined Enrollment 1 25 
Total 1 125 
P=0.206 (Binomial Test of Proportions) 
 
 
Table 44- Personal History of Hypertension 
 Positive History Negative History 
Participants Enrolled in the Database 33 67 
Participants who Declined Enrollment 10 16 
Total 43 83 
P=0.538 (Binomial Test of Proportions) 
 
 
Table 45- Personal History of Substance Abuse 
 Positive History Negative History 
Participants Enrolled in the Database 3 97 
Participants who Declined Enrollment 1 25 
Total 4 122 
P=0.547 (Binomial Test of Proportions) 
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Table 46- Personal History of Mental Illness 
 Positive History Negative History 
Participants Enrolled in the Database 7 93 
Participants who Declined Enrollment 1 25 
Total 8 118 
P=1.000 (Binomial Test of Proportions) 
 
 
Table 47- Personal History of Any Condition 
 
History of At Least One 
Condition 
No Personal History of a 
Condition 
Participants Enrolled in the Database 37 63 
Participants who Declined Enrollment 12 14 
Total 49 77 
P=0.417 (Binomial Test of Proportions)  
 
 
Table 48- Number of Conditions within a Personal History 
 0 1 2 3 
Participants 
Enrolled in the 
Database 
63 26 9 2 
Participants who 
Declined 
Enrollment 
14 7 2 3 
Total 77 33 11 5 
P=0.210 (Fisher’s Exact Test) 
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 Participants’ Family History Information 
 
Table 49- Opinion on the Effect of Family History on Risk 
 
Always 
Contributes to 
Risk 
Sometimes 
Contributes to 
Risk 
Never 
Contributes to 
Risk 
Unsure 
Participants Enrolled in the 
Database 48 42 1 9 
Participants who Declined 
Enrollment  8 15 1 2 
Total 56 57 2 11 
P= 0.231 (Fisher’s Exact Test) 
 
Table 50- Think they have a Positive Family History of a Chronic Condition 
 Positive Family History Negative Family History Uncertain 
Participants Enrolled in 
the Database 79 19 2 
Participants who 
Declined Enrollment 20 5 1 
Total 99 24 3 
P=0.703 (Fisher’s Exact Test) 
 
 
Table 51- Perceived Breast Cancer Risk 
 Low Risk Moderate Risk High Risk Don’t Know Risk 
Participants 
Enrolled in the 
Database 
64 25 7 3 
Participants who 
Declined 
Enrollment 
18 4 3 0 
Total 82 29 10 3 
P=0.533 (Fisher’s Exact Test) 
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  Table 52- Perceived Ovarian Cancer Risk 
 Low Risk Moderate Risk High Risk Don’t Know Risk 
Participants 
Enrolled in the 
Database 
52 23 3 3 
Participants who 
Declined 
Enrollment 
11 4 2 0 
Total 63 27 5 3 
P=0.461 (Fisher’s Exact Test) 
 
 
Table 53- Perceived Colon Cancer Risk   
 Low Risk Moderate Risk High Risk Don’t Know Risk 
Participants 
Enrolled in the 
Database 
58 29 8 4 
Participants who 
Declined 
Enrollment 
16 9 0 0 
Total 74 38 8 4 
P=0.452 (Fisher’s Exact Test) 
 
 
Table 54- Perceived Prostate Cancer Risk   
 Low Risk Moderate Risk High Risk Don’t Know Risk 
Participants 
Enrolled in the 
Database 
3 8 6 1 
Participants who 
Declined 
Enrollment 
3 5 0 0 
Total 6 13 6 1 
P=0.272 (Fisher’s Exact Test) 
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 Table 55- Perceived Heart Disease Risk   
 Low Risk Moderate Risk High Risk Don’t Know Risk 
Participants 
Enrolled in the 
Database 
28 40 28 4 
Participants who 
Declined 
Enrollment 
10 6 10 0 
Total 38 46  38 4 
P = 0.283 (Fisher’s Exact Test) 
 
 
Table 56- Perceived Lung Cancer Risk   
 Low Risk Moderate Risk High Risk Don’t Know Risk 
Participants 
Enrolled in the 
Database 
61 24 10 5 
Participants who 
Declined 
Enrollment 
18 7 1 0 
Total 79 31 11 5 
P=0.669 (Fisher’s Exact Test) 
 
 
Table 57- Perceived Diabetes Risk   
 Low Risk Moderate Risk High Risk Don’t Know Risk 
Participants 
Enrolled in the 
Database 
30 38 29 3 
Participants who 
Declined 
Enrollment 
13 6 6 0 
Total 43 42 35 3 
P=0.225 (Fisher’s Exact Test) 
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 Table 58- Perceived Alzheimer’s Disease Risk   
 Low Risk Moderate Risk High Risk Don’t Know Risk 
Participants 
Enrolled in the 
Database 
62 20 4 14 
Participants who 
Declined 
Enrollment 
19 3 3 1 
Total 81 23 7 15 
P=0.171 (Fisher’s Exact Test) 
 
 
Table 59- Perceived Hypertension Risk   
 Low Risk Moderate Risk High Risk Don’t Know Risk 
Participants 
Enrolled in the 
Database 
25 30 43 2 
Participants who 
Declined 
Enrollment 
6 6 13 0 
Total 31 36 56 2 
P=0.857 (Fisher’s Exact Test) 
 
 
Table 60- Perceived to be at High Risk for At Least One Condition 
 
High Risk for 1+ 
Condition 
Not High Risk for Any 
Conditions 
Participants Enrolled in the Database 61 39 
Participants who Declined Enrollment 14 12 
Total 75 51 
P=0.547 (Binomial Test of Proportions) 
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 Table 61- Number of Conditions Perceived to be High Risk  
 0 1 2 3 4 5 6 7 8 
Participants 
Enrolled in the 
Database 
39 23 17 12 5 2 1 0 1 
Participants 
who Declined 
Enrollment 
12 5 2 3 2 1 1 0 0 
Total 51 28 19 15 7 3 2 0 1 
P=0.704 (Fisher’s Exact Test) 
 
 
Table 62- Comparative Breast Cancer Risk 
 
Much 
Lower 
Risk 
Somewhat 
Lower 
Risk 
Same Risk
Somewhat 
Higher 
Risk 
Much 
Higher 
Risk 
Uncertain
Participants Enrolled 
in the Database 48 25 16 7 1 1 
Participants who 
Declined Enrollment 12 9 1 3 0 0 
Total 60 34 17 10 1 1 
P=0.487 (Fisher’s Exact Test) 
 
 
Table 63- Comparative Ovarian Cancer Risk 
 
Much 
Lower 
Risk 
Somewhat 
Lower 
Risk 
Same Risk
Somewhat 
Higher 
Risk 
Much 
Higher 
Risk 
Uncertain
Participants Enrolled 
in the Database 38 22 15 5 0 1 
Participants who 
Declined Enrollment 9 6 2 0 0 0 
Total 47 28 17 5 0 1 
P=0.783 (Fisher’s Exact Test) 
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 Table 64- Comparative Colon Cancer Risk 
 
Much 
Lower 
Risk 
Somewhat 
Lower 
Risk 
Same Risk
Somewhat 
Higher 
Risk 
Much 
Higher 
Risk 
Uncertain
Participants Enrolled 
in the Database 44 27 16 10 0 3 
Participants who 
Declined Enrollment 11 8 4 1 0 1 
Total 55 35 20 11 0 4 
P=0.90 (Fisher’s Exact Test) 
 
 
Table 65- Comparative Prostate Cancer Risk 
 
Much 
Lower 
Risk 
Somewhat 
Lower 
Risk 
Same Risk
Somewhat 
Higher 
Risk 
Much 
Higher 
Risk 
Uncertain
Participants Enrolled 
in the Database 5 3 6 3 0 1 
Participants who 
Declined Enrollment 3 4 1 0 0 0 
Total 8 7 7 3 0 1 
P=0.320 (Fisher’s Exact Test) 
 
 
Table 66- Comparative Heart Disease Risk 
 
Much 
Lower 
Risk 
Somewhat 
Lower 
Risk 
Same Risk
Somewhat 
Higher 
Risk 
Much 
Higher 
Risk 
Uncertain
Participants Enrolled 
in the Database 20 26 31 12 7 4 
Participants who 
Declined Enrollment 8 5 6 5 2 0 
Total 28 31 37 17 9 4 
P=0.645 (Fisher’s Exact Test) 
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 Table 67- Comparative Lung Cancer Risk 
 
Much 
Lower 
Risk 
Somewhat 
Lower 
Risk 
Same Risk
Somewhat 
Higher 
Risk 
Much 
Higher 
Risk 
Uncertain
Participants Enrolled 
in the Database 45 26 23 4 0 2 
Participants who 
Declined Enrollment 14 3 8 1 0 0 
Total 59 29 31 5 0 2 
P=0.481 (Fisher’s Exact Test) 
 
 
Table 68- Comparative Diabetes Risk 
 
Much 
Lower 
Risk 
Somewhat 
Lower 
Risk 
Same Risk
Somewhat 
Higher 
Risk 
Much 
Higher 
Risk 
Uncertain
Participants Enrolled 
in the Database 25 21 27 17 6 4 
Participants who 
Declined Enrollment 10 7 3 3 2 0 
Total 35 28 30 20 8 4 
P=0.397 (Fisher’s Exact Test) 
 
 
Table 69- Comparative Alzheimer’s Disease Risk 
 
Much 
Lower 
Risk 
Somewhat 
Lower 
Risk 
Same Risk
Somewhat 
Higher 
Risk 
Much 
Higher 
Risk 
Uncertain
Participants Enrolled 
in the Database 48 15 17 9 0 10 
Participants who 
Declined Enrollment 15 4 3 3 0 1 
Total 63 19 20 12 0 11 
P=0.831 (Fisher’s Exact Test) 
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 Table 70- Comparative Hypertension Risk 
 
Much 
Lower 
Risk 
Somewhat 
Lower 
Risk 
Same Risk
Somewhat 
Higher 
Risk 
Much 
Higher 
Risk 
Uncertain
Participants Enrolled 
in the Database 19 24 21 20 13 1 
Participants who 
Declined Enrollment 5 5 5 5 5 0 
Total 24 29 26 25 18 1 
P=0.946 (Fisher’s Exact Test) 
 
 
Table 71- Actual Risk for Heart Disease based upon Family History   
 Average Risk Moderate Risk High Risk 
Participants Enrolled 
in the Database 40 20 40 
Participants who 
Declined Enrollment 11 2 13 
Total 51 22 53 
P=0.335 (Fisher’s Exact Test) 
 
 
Table 72- Actual Risk for Stroke based upon Family History   
 Average Risk Moderate Risk High Risk 
Participants Enrolled 
in the Database 75 19 6 
Participants who 
Declined Enrollment 22 2 2 
Total 97 21 8 
P=0.410 (Fisher’s Exact Test) 
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 Table 73- Actual Risk for Diabetes based upon Family History   
 Average Risk Moderate Risk High Risk 
Participants Enrolled 
in the Database 47 21 32 
Participants who 
Declined Enrollment 16 4 6 
Total 63 25 38 
P=0.455 (Fisher’s Exact Test) 
 
 
Table 74- Actual Risk for Colon Cancer based upon Family History   
 Average Risk Moderate Risk High Risk 
Participants Enrolled 
in the Database 95 4 1 
Participants who 
Declined Enrollment 23 3 0 
Total 118 7 1 
P=0.331 (Fisher’s Exact Test) 
 
 
Table 75- Actual Risk for Prostate Cancer based upon Family History   
 Average Risk Moderate Risk High Risk 
Participants Enrolled 
in the Database 15 3 0 
Participants who 
Declined Enrollment 9 0 0 
Total 24 3 0 
P=0.529 (Fisher’s Exact Test) 
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 Table 76- Actual Risk for Breast Cancer based upon Family History   
 Average Risk Moderate Risk High Risk 
Participants Enrolled 
in the Database 87 7 6 
Participants who 
Declined Enrollment 23 1 2 
Total 110 8 8 
P=0.893 (Fisher’s Exact Test) 
 
 
Table 77- Actual Risk for Ovarian Cancer based upon Family History   
 Average Risk Moderate Risk High Risk 
Participants Enrolled 
in the Database 79 0 3 
Participants who 
Declined Enrollment 16 1 0 
Total 95 1 3 
P=0.235 (Fisher’s Exact Test) 
 
 
Table 78- Actual Risk for Endometrial Cancer based upon Family History   
 Average Risk Moderate Risk High Risk 
Participants Enrolled 
in the Database 81 0 1 
Participants who 
Declined Enrollment 16 0 1 
Total 97 0 2 
P=0.315 (Fisher’s Exact Test) 
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 Table 79- Actual Risk for Alzheimer’s Disease based upon Family History   
 Average Risk Moderate Risk High Risk 
Participants Enrolled 
in the Database 93 5 2 
Participants who 
Declined Enrollment 25 0 1 
Total 118 5 3 
P=0.480 (Fisher’s Exact Test) 
 
 
Table 80- Actual Risk for Hypertension based upon Family History   
 Average Risk Moderate Risk High Risk 
Participants Enrolled 
in the Database 33 16 51 
Participants who 
Declined Enrollment 8 8 10 
Total 41 24 61 
P=0.217 (Fisher’s Exact Test) 
 
 
Table 81- Family History of Substance Abuse 
 
2+ Relatives  (1º or 2º) 
with Substance Abuse  
0-1 Relatives (1º or 2º) 
with Substance Abuse 
Participants Enrolled in the Database 22 78 
Participants who Declined Enrollment 6 20 
Total 28 98 
P=0.816 (Binomial Test of Proportions) 
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 Table 82- Family History of Mental Illness 
 
2+ Relatives (1º or 2º) 
with Mental Illness 
0-1 Relatives (1º or 2º) 
with Mental Illness 
Participants Enrolled in the Database 7 93 
Participants who Declined Enrollment 1 25 
Total 8 118 
P=1.000 (Binomial Test of Proportions) 
 
 
Table 83- At High Risk for At Least One Condition Based upon Family History 
 Positive History Negative History 
Participants Enrolled in the Database 75 25 
Participants who Declined Enrollment 17 9 
Total 92 34 
P=0.261 (Binomial Test of Proportions) 
 
 
Table 84- Number of Conditions At High Risk For Based upon Family History 
 0 1 2 3 4 5 
Participants Enrolled 
in the Database 25 31 28 10 5 1 
Participants who 
Declined Enrollment 9 4 8 5 0 0 
Total 34 35 36 15 5 1 
P=0.357 (Fisher’s Exact Test)  
 
 
95 
 96 
Table 85- Number of Conditions in Which Risk was Over-Estimated 
 0 1 2 3 4 5 6 
Participants 
Enrolled in the 
Database 
28 22 10 26 6 4 4 
Participants who 
Declined 
Enrollment 
8 5 4 4 3 2 0 
Total 36 27 14 30 9 6 4 
P=0.644 (Fisher’s Exact Test) 
 
 
Table 86- Number of Conditions in Which Risk was Under-Estimated 
 0 1 2 3 4 5 
Participants Enrolled 
in the Database 48 30 16 5 0 1 
Participants who 
Declined Enrollment 16 5 5 0 0 0 
Total 64 35 21 5 0 1 
P=0.595 (Fisher’s Exact Test) 
 
 
Table 87- Number of Conditions in Which Risk was Accurately Estimated 
 0 1 2 3 4 5 6 7 
Participants 
Enrolled in the 
Database 
2 11 13 10 22 21 14 7 
Participants who 
Declined 
Enrollment 
0 1 2 6 4 7 2 4 
Total 2 12 15 16 26 28 16 11 
P=0.613 (Fisher’s Exact Test) 
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Pre-questionnaire 
An important aim of genetic counseling is to provide risk information so that individuals and families can 
make better informed decisions about their health and that of their families.  The purpose of this 
questionnaire is to explore your perceptions of risk for developing certain health conditions.  We want to 
understand whether family health histories (i.e., sharing information about diseases in your family) can 
help provide you with a more accurate assessment of your risk for developing particular health conditions.  
 
If there is a question that you do not feel comfortable answering, you can skip it and continue on.  Please 
answer the following questions to the best of your ability.  DO NOT PROVIDE ANY NAMES OF 
FAMILY MEMBERS.  The questionnaire should take approximately 10 minutes.  Thank you for your 
time. 
 
Section 1:  General Information 
 
1) What is your age? 
__ __ age in years 
 
2)  What is your gender? 
1 Male 
2 Female 
 
3) Are you Hispanic or Latino? 
1 Yes 
2 No 
3 Don’t know 
 
3a) Which one or more of the following would you say is your race?  (Check all that apply) 
1 White 
2 Black of African American 
3 Asian 
4 Native Hawaiian or Other Pacific Islander 
5 American Indian, Alaska Native 
6 Other [specify] __________________________ 
 
4) What was the total household income from all sources last year? 
1 Less than $10,000 
2 Between $10,000 and $20,000 
3 Between $20,001 and $35,000 
4 Between $35,001 and $50,000 
5 Between $50,001 and $75,000 
6 Greater than $75,000 
 
5) What is the highest grade or year of school you completed?   
1 Grades 8 or less (Elementary) 
2 Grades 9 through 11 (Some high school) 
3 Grade 12 or GED (High school graduate) 
4 College 1 year to 3 years (Some college or technical school) 
5 College 4 years or more (College graduate or post-graduate) 
6 Graduate level (Masters or PhD) 
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6) How would you rate your knowledge on genetics? 
1 Excellent 
2 Very good 
3 Good 
4 Fair 
5 Poor 
 
7) How would you describe your general health? 
1 Excellent  
2 Very good  
3 Good  
4 Fair  
5 Poor  
 
8) Do you have one person you think of as your personal doctor or health care provider? 
1 Yes, only one 
2 More than one 
3 No 
4 Don’t know / Not sure 
9) Was there a time in the past 12 months when you needed to see a doctor but could not because 
of the cost? 
1 Yes 
2 No 
3 Don’t know / Not sure 
 
10) Do you have any kind of health care coverage, including health insurance, prepaid plans such 
as HMOs, or government plans such as Medicare? 
1 Yes 
2 No 
3 Don’t know / Not sure 
 
Section 2:  Risk Perception 
 
11) Have you ever talked to a doctor or nurse about your concerns for developing a disease? 
1 Yes       Please describe: ___________________________________________________ 
2 No 
3 Don’t know / Not sure 
 
12) In your opinion, how often do you believe each of the following factors increases (or 
contributes to) an individual’s chance or risk for developing a disease such as diabetes, heart 
disease, and cancer?   (Please respond for each item listed) 
1=Never 2= Sometimes  3=Always  4=Don’t know / Not sure 
 
Smoking        _______ 
Having a poor diet       _______ 
Lack of exercise       _______ 
Family history (other family members with a disease)  _______ 
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13) What do you think the chances are of a healthy woman the same age as you to develop the 
following health conditions sometime in her life?   (Please respond for each condition listed) 
1=Low (<10%)        2=Moderate (10-50%)      3=High (>50%)     4=Don’t know / Not sure 
  
Breast cancer   _______ 
Ovarian cancer  _______ 
Colon cancer   _______ 
Cardiovascular disease _______ 
Lung cancer   _______ 
Diabetes   _______ 
Alzheimer’s disease  _______ 
Hypertension   _______ 
 
14) What do you think the chances are of a healthy man the same age as you to develop the 
following health conditions sometime in his life?   (Please respond for each condition listed) 
1=Low (<10%)        2=Moderate (10-50%)      3=High (>50%)     4=Don’t know / Not sure 
 
Breast cancer   _______ 
Colon cancer   _______ 
Prostate cancer  _______ 
Cardiovascular disease _______ 
Lung cancer   _______ 
Diabetes   _______ 
Alzheimer’s disease  _______ 
Hypertension   _______ 
 
15) Have you ever been concerned or worried about your chances for developing any of these 
health conditions? 
1 Yes 
2 No 
 
15a) If yes, which one(s)?  ____________________________________   
Please describe:  ____________________________________________ 
 
16) On a scale from 1 (not worried) – 5 (extremely worried), how would you rate your concern 
about developing any of the above health condition(s)?  _______ 
 
17) Do you have a blood relative (mother, father, sister, brother, uncle, aunt, grandmother, 
grandfather) who had or has a health condition that you are concerned about developing 
sometime in your life?   
1 Yes 
2 No 
3 Don’t know / Not sure 
 
17a) If yes, who and what was the health condition? *DO NOT INCLUDE NAMES OF 
FAMILY MEMBERS, ONLY THE RELATIONSHIP TO YOU 
______________________________________________________________________________ 
______________________________________________________________________________ 
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18) Have you ever talked to a health provider about your concern for developing that particular 
health condition? 
1 Yes 
2 No 
3 Don’t know / Not sure 
 
19) At this time, what do you think your chances are of developing any of the following health 
conditions sometime in your life?   (Please respond for each condition listed) 
1=Low (<10%)        2=Moderate (10-50%)      3=High (>50%)     4=Don’t know / Not sure  
 
Breast cancer    ______ 
Ovarian cancer (Women Only) ______ 
Colon cancer    ______ 
Prostate cancer (Men Only)  ______ 
Cardiovascular disease  ______ 
Lung cancer    ______ 
Diabetes    ______ 
Alzheimer’s disease   ______ 
Hypertension    ______ 
 
20) At this time, what do you think your chances are of developing any of the following health 
conditions someday, compared with most individuals your age?  (Please respond for each 
condition listed) 
1=Much lower   2=Somewhat lower     3=Same     4=Somewhat higher   
5=Much higher    6=Don’t know / Not sure 
 
Breast cancer    _______ 
Ovarian cancer (Women Only) _______ 
Colon cancer    _______ 
Prostate cancer (Men Only)  _______ 
Cardiovascular disease  _______ 
Lung cancer    _______ 
Diabetes    _______ 
Alzheimer’s disease   _______ 
Hypertension    _______ 
 
Thank you very much for your help with our questionnaire.  We would appreciate any 
comments/feedback about your experience. 
 
__________________________________________________________________________ 
__________________________________________________________________________ 
__________________________________________________________________________ 
__________________________________________________________________________
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Study Post-Questionnaire 
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Post-questionnaire 
We hope that you enjoyed having your family health history done.  We would like to ask you a few more 
questions about risk to see if the family health history session changed your ideas about what conditions 
you might be at risk for.  In addition, this post-session questionnaire is looking at your opinions regarding 
participating in research.   
If there is a question that you do not feel comfortable answering, you can skip it and continue on.  Please 
answer the following questions to the best of your ability.  DO NOT PROVIDE ANY NAMES OF 
FAMILY MEMBERS.  The questionnaire should take approximately 10 minutes.  We would like to 
thank you in advance for your willingness to participate in this study. 
 
Section 1: Risk Perception 
 
1)  Based on your family health history, what do you think your chances are of developing any of 
the following health conditions sometime in your life?  
(Please respond for each condition listed) 
1=Low (<10%)        2=Moderate (10-50%)      3=High (>50%)     4=Don’t know / Not sure  
Breast cancer    _______ 
Ovarian cancer (Women Only) _______ 
Colon cancer    _______ 
Prostate cancer (Men Only)  _______ 
Cardiovascular disease  _______ 
Lung cancer    _______ 
Diabetes    _______ 
Alzheimer’s disease   _______ 
Hypertension    _______ 
 
2) Based on your family health history, what do you think your chances are of developing any of 
the following health conditions someday, compared with most individuals your age?    
(Please respond for each condition listed) 
1=Much lower   2=Somewhat lower     3=Same     4=Somewhat higher   
5=Much higher    6=Don’t know / Not sure 
Breast cancer    _______ 
Ovarian cancer (Women Only) _______ 
Colon cancer    _______ 
Prostate cancer (Men Only)  _______ 
Cardiovascular disease  _______ 
Lung cancer    _______ 
Diabetes    _______ 
Alzheimer’s disease   _______ 
Hypertension    _______ 
 
Section 2: Opinions on Research 
 
3)  How important do you feel that medical research is? 
1 Very important 
2 Somewhat important 
3 Not very important 
4 Not important at all 
5 Don’t know 
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4)  Have you ever participated as a subject in any medical research studies? 
1 Yes 
2 No 
3 Don’t know 
 
5)  Have you ever been offered the chance to participate in a medical research study and decided 
not to participate? 
1 Yes 
2 No  
3 Don’t know 
 
6)  If you were to describe your general attitude towards medical research involving people, 
would you say that you feel? 
1 Very favorable 
2 Somewhat favorable 
3 Somewhat unfavorable 
4 Very unfavorable 
5 Neither favorable nor unfavorable 
6 Don’t know 
 
7)  Would the offer of free medical care make you more likely or less likely to agree to 
participate in research? 
1 More likely 
2 Less likely 
3 No effect 
4 Don’t know 
 
8)  Would the offer of $500 make you more likely or less likely to agree to participate in 
research? 
1 More likely  
2 Less likely 
3 Have no effect 
4 Don’t know 
 
9)  Would the offer of free medicine make you more likely or less likely to agree to participate in 
research? 
1 More likely  
2 Less likely 
3 Have no effect 
4 Don’t know 
 
10)  How much do you think scientists benefit from medical research? 
1 A great deal 
2 A moderate amount 
3 Only a little 
4 Not at all 
5 Depends
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11) How much do you think your community benefits from medical research? 
1 A great deal 
2 A moderate amount 
3 Only a little 
4 Not at all 
5 Depends 
 
12)  How much do you think your family and friends benefit from medical research? 
1 A great deal 
2 A moderate amount 
3 Only a little 
4 Not at all 
5 Depends 
 
13)  How much do you think you benefit from medical research? 
1 A great deal 
2 A moderate amount 
3 Only a little 
4 Not at all 
5 Depends 
 
14)  Do you have an interest in having your name in a database that would allow you to receive 
information about clinical research studies related to your family health history?  
NOTE: Answering YES to this question DOES NOT enter you into any database nor does 
it sign you up to receive any information.   
1 Yes 
2 No 
 
14a)  If you answered yes, what are your expectations? (Please circle all that apply) 
1 I expect to receive information about all of the latest research studies. 
2 I expect to receive information about studies that I am eligible for.  
3 I expect to be rewarded for participating in research (paid, free health care, etc.) 
4 I expect to get the best health care available. 
5 Other:_________________________________________________________ 
 
14b)  If you answered no, what are your primary reasons? (Please circle all that apply) 
1 I am not interested in participating in research. 
2 I am not interested in anything tied to my family/my genetics. 
3 I do not want to be part of a database. 
4 I do not want to disclose my contact information. 
5 Other:_______________________________________________________ 
 
15)  How would you describe your experience with having your family health history taken? 
(Please circle all that apply) 
1 Enjoyable 
2 Informative 
3 Uncomfortable/Unpleasant 
4 Neutral/No opinion 
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1-Month Telephone Follow-Up 
Date: __________________ 
 
Person Making Phone Call: _______________________________ 
 
 
INTERVIEWER: ASK TO SPEAK WITH THE INDIVIDUAL WHO GAVE US HIS OR HER 
NAME AND TELEPHONE NUMBER.  IF YOU ARE TOLD THAT THE PERSON IS NOT 
HOME, SCHEDULE A CALL-BACK.  WHEN YOU ARE SPEAKING WITH THE 
INDIVIDUAL, READ… 
 
Hi, my name is ________ and I am a genetic counseling student from The University of 
Pittsburgh with the Center for Minority Health.  About a month ago, you completed a 
questionnaire and had your family health history completed at ____________.  As you may 
recall, you agreed to let us contact you for a follow-up questionnaire.  I just have a couple of 
brief questions to ask you.  It should take about five minutes.  Is it okay to proceed with the 
questions?   
 
 
1) After having your family health history done, how did it make you feel?    
 
 
 
 
 
2) Did you tell any one about having your family health history drawn out?   
 
 
 
3) (IF THE PERSON SAYS YES TO #2) Who did you tell and what did you tell them? 
 
 
 
 
 
 
4) Has anything about your family health history changed since we met? 
 
 
 
 
 
 
5) Did you add (that or) anything else you may have remembered to your family health history? 
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6) Did you look over the materials/information we sent you with your family health history? 
 
 
 
7) (IF THE PERSON SAYS YES TO #6) Did you find them helpful? 
 
 
 
 
 
 
8) Would you like any additional information? 
 
 
 
 
 
 
 
 
 
 
9) Have you seen a health care professional since you had you had your family health history 
done? 
 
 
 
10) (IF THE PERSON SAYS YES TO #9) Did you share your family health history with the 
health care professional? 
 
 
 
 
 
 
11) (IF THE PERSON SAYS YES TO #10) What did he or she say about it? 
  
12) Do you have any plans to share your family health history with your family in the next six 
months? 
 
 
 
 
 
 
 
 
13) Do you plan to share your family health history with a health care professional (i.e., doctor, 
nurse, pharmacist, physician assistant, or genetic counselor) in the next six months? 
 
 
 
 
 
 
14) Have you made any lifestyle changes (diet/exercise/smoking/increased screening) since we 
did your family health history? 
 
 
 
 
 
 
15) (IF THE PERSON SAYS NO TO #14) Do you want to or are you planning on making any 
changes?
 
 
 
 
 
 
16) (IF THE PERSON SAYS YES TO #15) What do you find to be the barriers for you to 
making changes? 
 
 
 
 
 
 
17) (IF THE PERSON SAYS YES TO #15) Do you think support groups or classes would help 
you make the changes you want to? 
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APPENDIX F 
 
 
 
Sample of Materials Sent to Family Health History Participants 
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Figure 8- Certificate of Appreciation Sent to All Family Health History Participants 
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Figure 9- Sample Computer-Generated Family Health History Using Progeny Software 
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Figure 10- Sample Patient Education Material 
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